Medicine 2 Flashcards

(647 cards)

1
Q

Thrombophilia

A

= inherited / acquired coagulopathy predisposing to thrombosis (usually venous).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Causes of Inherited vs Acquired thrombophilia

A

INHERITED
- APC resistance / Factor V Leiden mutation
- Antithrombin III deficiency
- Prothrombin gene mutation

ACQUIRED:
APL syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Indications for screening a patient for thrombophilia

A
  • Arterial thrombosis <50
  • Venous thrombosis <40 with no RFs
  • Familial VTE
  • Recurrent unexplained VTE
  • Unusual site of thrombosis (e.g. mesenteric or portal vein thrombosis)
  • Recurrent miscarriage (>3)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Thrombophilia- Ix

A
  • FBC
  • Clotting
  • Fibrinogen concentration +/- APC resistance test
  • Lupus anticoagulant / anti cardio-lipin antibodies
  • Anti-thrombin and Protein C/S assays for deficiency
  • Factor V Leiden mutation PCR (if APC resistance test positive)
  • PCR for prothrombin gene mutation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Definition of anaemia

What can cause it ?

A

= decreased haemoglobin in the blood, such that there is inadequate oxygen delivery to tissues.

=> Hb <135 g/L in men; Hb <115 g/L in women.

Patients become anaemia when they are:
1. Not making enough RBCs
=> Reduced erythropoiesis (or haematopoiesis)

  1. Losing or breaking down RBCs too quickly.
    => Bleeding
    => Haemolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Anaemia - symptoms

A

Often asymptomatic => a slowly falling Hb allows for haemodynamic compensation.

Non-specific = Fatigue, weakness, headaches

CV = dyspnoea, intermittent claudication, palpitations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Anaemia - signs

A

GENERAL:
Pallor
Tachycardia
Systolic flow murmur
Cardiac Failure

SPECIFIC:
Koilonychia – IDA
Jaundice – haemolytic anaemia
Leg ulcers – often seen in sickle cell disease
Bone marrow expansion, leading to abnormal facial structure or pathological #s in thalassaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Transfusions in anaemia

A

Transfusion is generally not indicated if there is no acute bleed, and the patient is not symptomatic.

If the anaemia is severe and requires transfusion, beware of associated heart failure:
=> Transfusion should be given very slowly, alongside furosemide.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

RBC Lifecycle

A

Erythropoiesis occurs in the bone marrow.
=> Stimulated by erythropoietin (EPO) produced by the kidneys.

Average RBC lifespan is 120 days.

The ageing RBC are removed from the circulation.

This process normally occurs at the same rate of production by erythropoiesis, balancing the total circulating red blood cell count hence patients have a stable Hb.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Microcytic anaemia - causes

A

Low Hb, Low MCV

Iron deficiency anaemia (IDA)
Thalassaemia
Lead poisoning
Sideroblastic anaemia (rare)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Normocytic anaemia - causes

A

Low Hb, normal MCV

Acute blood loss
Anaemia of chronic disease
Renal anaemia
Haemolytic anaemias (or macrocytic)
Marrow failure
Pregnancy
CTDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Macrocytic anaemia - causes

A

Low Hb, High MCV

B12 deficiency
Folate deficiency
Alcohol Excess (or severe liver disease)
Myelodysplastic Syndromes
Severe hypothyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Iron deficiency anaemia - causes

A

BLOOD LOSS UNTIL PROVEN OTHERWISE
Hookworm
Heavy menstruation
GI bleeds

DECREASED ABSORPTION
Coeliac disease
Patients on antacids (less ferric to ferrous iron conversion)
Post-gastrectomy

INCREASED DEMAND
Growth
Pregnancy

INADEQUATE INTAKE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Iron Deficiency Anaemia - Ix

A
  1. Clinical examination for signs of iron deficiency
    - Koilonychia
    - Angular stomatitis
    - Brittle nails/hair
  2. Blood Tests:
    - Iron studies
  • Blood film:
    => Microcytic anaemia is generally also hypochromic (pale on the blood film, representing MCH)
    => Film may show signs of sideroblasts/signs of thalassaemia
  1. Further tests:
    => If there is a good history of menorrhagia, start oral iron and only further Ix is coeliac serology.

=> In all other patients, without an obvious cause of bleeding:
- Check coeliac serology
- Refer for OGD and colonoscopy
- Stool microscopy is advised if recent foreign travel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is measured in iron studies?

A
  • Serum iron
  • Serum ferritin
  • Total Iron binding capacity
  • Serum soluble transferrin receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Iron Deficiency Anaemia - Mx

A

Address the underlying cause as appropriate – e.g. menorrhagia, GI bleed, etc.

Lifestyle:
=> Advise increased dietary intake of dark green vegetables, fortified bread/cereals, lead red meat, prunes/raisins

Commence oral ferrous sulphate 200 mg t.d.s and before awaiting investigation results
=> Can start with b.d. as may be better tolerated

If ferrous sulphate is not tolerated, consider switching to ferrous gluconate.

Monitor for improvement in Sx and blood parameters after 1 month of Tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

SEs of ferrous sulphate

A

cramping, bloating, nausea, vomiting, constipation, black stools.

Adverse effects can be decreased if taken with meals

Can offer laxatives for constipation or dose reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How long should Tx with iron be continued in IDA?

A

Tx should be continued for 3 months after blood parameters return to normal, to replenish supplies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Rule of 10 for anaemia

A

The maximum rise in Hb concentration is one week is 10 g/L

If more than 10 g/L decline is seen over a week, then blood is being lost.

When transfusing, one bag will raise the Hb concentration by 10 g/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Anaemia of chronic disease

A

Can be microcytic or normocytic, therefore can be a differential for IDA.

Ix:
- Serum iron will be decreased
- TIBC will also be decreased
- STR – normal
- Ferritin will be raised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Plummer-Vinson Syndrome

A

A rare disease characterised by dysphagia, odynophagia, IDA, glossitis, chelitis and oesophageal webs.

Generally occurs in post-menopausal women

Tx:
=> Iron supplementation and mechanical widening of the oesophagus provides a good outcome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is thalassaemia?

A

= Genetic disorders of Hb synthesis

Common in the middle/far East

Caused by deficient alpha or beta chain synthesis, thus resulting in alpha- or beta- thalassaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Beta-Thalassaemia

A

MINOR (“trait”)
- Carrier state
- Usually asymptomatic
- Gives a mild microcytic anaemia that may worsen in pregnancy
- HbA2 is raised, with slightly raised HbF also

MAJOR (“Cooley’s anaemia”)
- Abnormality in both globin genes
- Presenting within the first year with severe anaemia, hepatosplenomegaly and failure to thrive.
- Extramedullary haematopoiesis results in facial deformities.
- Survival is possible due to HbF

  • Blood film – hypochromic microcytic cells, also target cells and nucleated RBCs
  • Mx = lifelong blood transfusions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Alpha-thalassaemia

A

Bart’s hydrops:
- Deletion of all 4 alpha-globin genes
- This form of Hb is physiologically useless and leads to death in utero

Deletion of 3 genes:
- Moderate microcytic anaemia
- Features of haemolysis

Deletion of 2 genes:
- Asymptomatic carrier state, with reduced MCV

Deletion of 1 gene:
- Clinically normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Anaemia screening before surgery
Anaemia is the most common abnormality seen in pre-op patients: <60 g/L will require transfusion <100 g/L may require transfusion depending on cardiac risk and anticipated blood loss.
26
What is myeloma?
= a malignant clonal proliferation of plasma cells (derived from B-lymphocytes). Normally, many different plasma cells produce a range of immunoglobulins – i.e. they are polyclonal. In myeloma, a single clone of plasma cells produces a single immunoglobulin. => When you measure the immunoglobulins in a patient with myeloma, one of the type of antibody will be significantly abundant
27
Myeloma - RFs
Older age (average age of presentation is 70) Black African ethnicity FHx Obesity
28
Myeloma - presentation
“CRAB” – calcium, renal, anaemia, bone: Osteolytic bone lesions (due to osteoclast activation) => Backache, pathological fractures, hypercalcaemia (bones, stones, moans and groans) Bone marrow failure => Infection, symptoms of anaemia, bleeding Renal impairment => Seen in 20% at diagnosis, due to light chain deposition
29
Myeloma - complications
Hypercalcaemia, Spinal cord compression, Hyper-viscosity, Acute renal failure.
30
Myeloma - Ix
FBC – normochromic normocytic anaemia; leucopaenia Blood film – rouleaux formation ESR – raised U&Es – often deranged Calcium – raised ALP – normal Serum/urine electrophoresis => Paraprotein monoclonal band seen Urine Bence-Jones protein – positive Skeletal XR => Punched out lytic lesions Bone marrow biopsy => Increased clonal plasma cells >10% => If under 10%, may be termed “monoclonal gammopathy of uncertain significance” (MGUS)
31
Myeloma - Mx
- Supportive therapy - Chemotherapy - Radiotherapy - Bone marrow stem cell transplants used if <70
32
Myeloma - prognosis
The original myeloma cell is very resistant, so often returns. Median survival is 3-4 years. Death is usually from renal failure/infection.
33
What is lymphoma?
= malignant proliferation of lymphocytes. Most commonly accumulate in peripheral lymph nodes, but can accumulate in the peripheral blood or infiltrate organs. Most are derived from B cells. Classified as Hodgkin's or Non-Hodgkin's
34
What is Hodgkin's Lymphoma?
Characterised by Reed-Sternberg cells => Binucleate “mirror cells” on biopsy. Largest peak of incidence is young adults (20-35 years) Second peak in 50-70-year olds. Disease is slow growing, usually localised and rarely fatal.
35
RFs for Hodgkin's Lymphoma
- Affected sibling - HIV, EBV - Autoimmune conditions – e.g. SLE, RA - FHx
36
Hodgkin's Lymphoma - Presentation
Enlarged, non-tender, “rubbery” lymph nodes (typically cervical) Fatigue, itching 25% will have B-symptoms, with profuse night sweats. For some patients, alcohol can induce lymph node pain Mediastinal lymph nodes can have mass effects (SVC/bronchial obstruction) O/E: - Lymphadenopathy - Hepatosplenomegaly in 50% - Potentially signs of cachexia/anaemia
37
What is Non-Hodgkin's Lymphoma?
Includes all lymphomas without the presence of Reed-Sternberg cells. Peak incidence = 70 years Can be further classes into high/low grade => HIGH grade – divide rapidly, typically present with rapid onset lymphadenopathy; more aggressive but better prognosis if identified and treated. => LOW grade – divide slowly, typically present more insidiously and thus tend to be widely disseminated at diagnosis, often incurable.
38
Non-Hodgkin's Lymphoma - Presentation
Nodal disease – 75% have superficial lymphadenopathy Extra-nodal disease – oropharynx, skin, CNS, gut, lung B-symptoms – weight loss indicates disseminated disease. Bone marrow failure Presentation is similar to Hodgkin’s lymphoma and often they can only be differentiated when the lymph node is biopsied.
39
Lymphoma - Ix
FBC, U&E, LFT, ESR, blood film, Ca2+ LDH => Often raised in Hodgkin’s lymphoma but is not specific and can be raised in other cancers and many non-cancerous diseases. Lymph node biopsy is the key diagnostic test. => Reed-Sternberg cells in Hodgkin’s Lymphoma Staging CT/MRI/PET
40
Ann Arbor Staging
The staging system used for both Hodgkins and non-Hodgkins lymphoma. The system puts importance on whether the affected nodes are above or below the diaphragm. Stage 1: Confined to one region of lymph nodes. Stage 2: In more than one region but on the same side of the diaphragm (either above or below). Stage 3: Affects lymph nodes both above and below the diaphragm. Stage 4: Widespread involvement including non-lymphatic organs such as the lungs or liver.
41
Lymphoma - Mx
HODGKIN'S - Chemotherapy - Radiotherapy - Chemo-radiotherapy NON-HODGKIN'S Involves a combination of treatments depending on the type and staging of the lymphoma: - Watchful waiting - Chemotherapy - Monoclonal antibodies such as rituximab - Radiotherapy - Stem cell transplantation
42
Macrocytic anaemia - Ix
Blood film => Hyper segmented neutrophils in B12/folate deficiency LFTs / TFTs => ?Thyroid / hepatic cause => Raised bilirubin in B12/folate deficiency Serum B12 and folate levels If B12 low: - Anti-parietal cell antibodies - Anti-intrinsic factor antibodies - Schilling test Bone marrow biopsy:  Megaloblasts suggest B12/folate deficiency (also seen in myelodysplasia)  Deoxyuridine suppression test – can be used to differentiate B12/folate deficiency in vitro after bone marrow biopsy.
43
What can be a problem with measuring serum folate levels?
Serum folate reflects recent intake, so many labs do red cell folate.
44
Schilling test
distinguishes between pernicious anaemia and small bowel disease Radiolabelled B12 given with and without IF The amount of labelled B12 excreted in the urine then detected.
45
How does B12/folate deficiency lead to macrocytic anaemia?
B12 acts as a co-enzyme for the conversion of folate (B9) to activated folate. Activated folate is required for DNA synthesis, and thus if there is a deficiency in either B12 or folate, DNA synthesis malfunctions. In this case, the DNA fails to stop erythrocyte development, leading to very large cells, which are eventually trapped and destroyed in the reticulo-endothelial system.
46
B12 absorption
Intrinsic factor is secreted by gastric parietal cells, and binds free B12. Receptors for the IF-B12 complex are present on the brush border of the terminal ileum, where B12 is absorbed. IF is generally necessary for B12 ingestion, but even in its complete absence, around 2% of B12 can still be absorbed.
47
Sources of B12
Humans rely on animal sources of B12 – e.g. meat, fish, eggs and milk. The liver contains very large stores of B12 => It is secreted in bile but most of this is normally reabsorbed.
48
Pernicious Anaemia - Mx
high dose PO B12 supplementation can be enough to treat pernicious anaemia (as ~2% can still be absorbed in the abscence of IF) Initially patients are often treated with IM B12 on alternate days before switching to PO for maintenance
49
Causes of B12 deficiency
Chronic low dietary intake – vegans Impaired binding in the stomach – pernicious anaemia, congenital absence of IF, gastrectomy. Small bowel disease – resection, Crohn’s/backwash ileitis in UC, bacterial overgrowth. (Pancreatitis, coeliac disease and metformin can all cause mild impairment of B12 absorption, but not enough to cause significant B12 deficiency. )
50
Pernicious anaemia
= Autoimmune disease, resulting in severe B12 deficiency There are 3 autoantibodies that may contribute towards disease: 1. Autoantibodies against parietal cells 2. Blocking antibodies - Prevent IF-B12 binding - Most common abnormality 3. Binding antibodies: - Prevent IF binding to ileal receptors
51
Subacute degeneration of the spinal cord
Simultaneous dorsal column and corticospinal tract loss due to B12 deficiency => Gives a combination of UMN and LMN signs. Initial presentation is with peripheral neuropathy O/E there is classical triad of extensor plantars, brisk knee jerk reflex but absent ankle jerk reflex => Tone and power usually normal => Gait may be ataxic
52
Sources of folate
Folate (folic acid monoglutamate) is not itself present in nature, but occurs as polyglutamates dihydrofolate (DHF) or tetrahydrofolate (THF) These are found in green vegetables and offal (however cooking causes a loss of up to 90% of the folate). DHF and THF are converted to folate in the upper GI tract, and folate is absorbed in the jejunum
53
Causes of folate deficiency
Poor nutritional intake – poor diet, alcohol excess, anorexia. Malabsorption – coeliac disease Anti-folate drugs – trimethoprim, methotrexate, anti-convulsants Excess physiological use – pregnancy, lactation, prematurity. Excess pathological use – excess erythrocyte production, malignancy, inflammatory diseases
54
Folate deficiency - Mx
Folic acid 5 mg/day PO for 4 months Always combined with B12, unless the patient is known to have normal B12 levels.
55
Approach to normocytic anaemia
Is there acute blood loss? Is there underlying chronic disease? Is it haemolytic? Are other cell lines affected (i.e. bone marrow failure)?
56
Anaemia of chronic disease
Normochromic or hypochromic, rarely severe. Seen in chronic infection, malignancy, CKD, rheumatoid disorders. Pathology involves predominant WBC production in the bone marrow. Low serum iron, raised ferritin, low TIBC, normal STR.
57
Bone marrow failure - investigations - causes
Hb, reticulocytes, WBC and platelets all equally low. There will be alterations on the blood film These patients require bone marrow biopsy. No abnormal blasts in pancytopaenic marrow = aplastic anaemia (idiopathic or due to drugs). Other causes will be apparent on marrow examination => E.g. haematological malignancies, metastatic disease, myelofibrosis, myelodysplasia. Parvovirus infection can also cause cessation of marrow erythropoiesis.
58
Myeloproliferative Disorders
A group of disorders including – myelofibrosis, polycythaemia rubra vera, and essential thrombocytosis. Clones of haematopoietic stem cells proliferate in the marrow, yet retain the ability to differentiate. Considered PRE-LEUKAEMIC.
59
Essential Thrombocytosis
Clonal proliferation of megakaryocytes, leading to persistently raised platelets => This is often asymptomatic => The platelets have abnormal function Symptoms: => The most common presentation is microvascular occlusion. => Other symptoms may be related to bleeding or arterial/venous thrombosis.
60
Polycythaemia Rubra Vera (PCV)
= Malignant proliferation of a clone derived from one pluripotent marrow cell. Excess production of RBCs, WBCs and platelets lead to serum hyper-viscosity and thrombotic complications. Presentation: - Often asymptomatic - Arterial/venous thrombosis - Rarer – vague hyperviscosity symptoms (headache, dizziness, tinnitus, facial swelling, burning sensation in fingers/toes; splenomegaly; gout.
61
Polycythaemia Rubra Vera - Ix and Mx
Diagnosis: - Increased red cell mass - Ix for JAK2 mutation (PCV cells often carry activating mutation in the tyrosine kinase (JAK2) gene) Key differentials to r/o = hypoxia and renal disease (in these secondary PCV’s only the RBCs are raised). Treatment: - Repeated venesection - Low dose aspirin
62
Primary Myelofibrosis
= Hyperplasia of megakaryocytes, which produce excess platelet-derived growth factor, leading to marrow fibrosis and metaplasia. There is secondary haematopoiesis in the liver/spleen, leading to massive hepatosplenomegaly (= most common presentation). Symptoms: - B symptoms - Abdominal discomfort - Sx of bone marrow failure Essential thrombocytopaenia and PCV both may progress to myelofibrosis or AML, yet the risk is relatively rare.
63
Aplastic Anaemia
= A rare stem cell disorder leading to pancytopenia and hypoplastic bone marrow. Most commonly autoimmune Triggered by drugs, viruses or irradiation. Can be inherited (Fanconi anaemia) Symptoms are of bone marrow failure Diagnosis is with bone marrow biopsy.
64
Aplastic Anaemia - Mx
Blood product transfusion Immunosuppression in autoimmune conditions In younger patients, allogenic bone marrow transplant may be curative.
65
What is haemolysis? Where can it occur? How does it present?
= the breakdown of RBCs before the end of their normal lifespan (120 days). Can be: 1. Intravascular 2. Extravascular (reticuloendothelial system of the liver, spleen and bone marrow). This may be asymptomatic, but haemolytic anaemia develops if the bone marrow does not sufficiently compensate.
66
Causes of haemolysis
INTRINSIC Haemoglobinopathies – e.g. sickle cell/thalassaemias Membranopathies – spherocytosis/elliptocytosis Enzymeopathies – G6PD/PK deficiency EXTRINSIC Autoimmune disease Alloimmune disease – transfusion/transplant reaction, rhesus disease Drug-induced – e.g. penicillins Infection – malaria and some other parasites Microangiopathic haemolytic anaemias – e.g. DIC
67
Haemolysis - Ix
Signs suggestive of increased RBC breakdown: - Anaemia with raised MCV - Raised bilirubin – unconjugated, pre-hepatic jaundice - Raised serum LDH (gets released from RBCs) Signs suggestive of increased RBC production: - Raised reticulocyte count BLOOD FILM can give clues as to the cause Further tests: - Coomb’s test (DAT) = Identifies RBCs coated with antibodies or complement, indicating an immune cause of haemolysis. - Hb electrophoresis = Can identify different haemoglobinopathies - Enzyme assays = If other causes have been excluded
68
What aspects of a blood film can show the cause of haemolysis?
Hypochromic, microcytic cells – thalassaemia Sickle cells – SCA Spherocytes – hereditary spherocytosis or autoimmune haemolytic anaemia Elliptocytes – hereditary elliptocytosis Heinz bodies / “bite” cells – G6PD deficiency Schistocytes – microangiopathic haemolytic anaemia
69
Glucose-6-phosphate dehydrogenase (G6PD) deficiency - Inheritance and Presentation
X-linked inheritance => More common in African and Mediterranean males (females will have mild symptoms). Presentation: - Mostly asymptomatic, but susceptible to oxidative crises due to reduced glutathione production. - These attacks cause rapid anaemia and jaundice with “bite cells” and “blister cells” seen on the blood film. Attacks may be precipitated by drugs (aspirin, primaquine, sulphonamides), broad bean consumption or illness.
70
G6PD - Ix and Mx
Diagnosis is with enzyme assay 3 months after initial crisis BITE CELLS on blood film Tx: - Precipitant avoidance (e.g. broad beans) - Transfusion if severe - Splenectomy may help with chronic haemolysis
71
Pyruvate Kinase (PK) Deficiency - Inheritance and presentation
Autosomal recessive condition Reduced ATP production, shortening the lifespan of RBCs Homozygotes usually present with neonatal jaundice and later chronic jaundice with hepatosplenomegaly.
72
Pyruvate Kinase (PK) Deficiency - Ix and Management
Dx = enzyme assay Tx = Often well tolerated and no specific therapy is needed, although splenectomy may help.
73
Hereditary Spherocytosis
Autosomal dominant membrane defect => Leading to spherical RBCs These are less deformable, thus can become trapped in the spleen => leads to haemolysis, splenomegaly and jaundice.
74
Hereditary Elliptocytosis
Autosomal dominant defect => "elliptocytes" Mostly asymptomatic
75
Mx of membranopathies (spherocytosis/elliptocytosis)
Both are treated with folate. Splenectomy is curative, but reserved for severe disease.
76
What causes Sickle cell disease?
= Autosomal recessive disorder Causes abnormal production of beta-globulin chains, due to a single amino acid substitution (glu6val) This results in the production of HbS rather than HbA Much more common in patients of African origin There are two genotypes: - HbSS – sickle cell anaemia phenotype - HbAS – sickle cell trait
76
What causes Sickle cell disease?
= Autosomal recessive disorder Causes abnormal production of beta-globulin chains, due to a single amino acid substitution (glu6val) This results in the production of HbS rather than HbA Much more common in patients of African origin There are two genotypes: - HbSS – sickle cell anaemia phenotype - HbAS – sickle cell trait HbS polymerises when deoxygenated, causing RBCs to form “sickle cells” which are fragile and haemolyse, and can also block small vessels
77
HbAS – sickle cell trait
HbAS confers protection from falciparum malaria rarely symptomatic => BUT vaso-occlusive events may occur in hypoxia – e.g. when flying or under anaesthesia
78
Sickle cell disease - Ix
Usually on the newborn bloodspot screening Sickle cells can be seen on blood film Hb electrophoresis can confirm diagnosis and also distinguish variants.
79
Sickle Cell disease - Presentation
Often presents in the first few months of life, with anaemia developing as HbF levels fall. Acute haemolytic crises occur, causing bone infarcts and painful dactylitis Untreated, there is: - Splenic infarction, leading to hyposplenism - Renal infarction, causing CKD - Cerebrovascular accidents In adulthood, there is normally a chronic haemolytic anaemia (60-90 g/L) but this is well tolerated unless there is a crisis.
80
Complications of sickle cell disease
Hyposplenism, CKD, Bone necrosis, Chronic leg ulcers, Iron overload (if multiple transfusions) Long-term pulmonary damage
81
Sickle cell disease - Long-term Tx
Lifelong folate supplementation Pneumococcal vaccination and prophylactic penicillin (due to hyposplenism) Hydroxycarbamide (hydroxyurea) can help by increasing HbF production and is advised if there are frequent crises. Regular life-long transfusions (2-4 weekly), with iron chelators to prevent overload. Bone marrow transplantation is curative – but limited by availability of matched donors.
82
Sickle-cell - Vaso-occlusive Crises
PAINFUL CRISES Occur due to micro-vascular occlusion, often affecting the bone marrow, causing severe pain. Can be precipitated by cold, infection, dehydration or hypoxia. Other presentations are mesenteric ischaemia (mimicking acute abdomen), cerebral infarctions or priapism
83
Sickle cell - aplastic crises
Due to parvovirus B19 Causes a sudden reduction in marrow production (particularly RBCs) Usually self-limiting, but transfusion may be required.
84
Sickle cell - sequestration crises
Mainly affects children as spleen has not yet undergone atrophy. Pooling of blood in the spleen +/- liver, with organomegaly, severe anaemia and shock Urgent transfusions are required.
85
Sickle cell - haemolytic crises
Rarer Hb falls due to haemolysis
86
Mx of sickle cell crises
A-E resuscitation – high flow oxygen and IV fluids Strong analgesia within 30 minutes FBC, reticulocytes, XM blood Screen for signs of infection (culture, MSU, CXR) & treat early. Prophylactic enoxaparin should be given Fully cross-matched blood transfusion if Hb/reticulocytes fall sharply. Exchange transfusion if rapidly deteriorating.
87
Autoimmune Haemolytic Anaemia
Autoantibodies lead to extravascular haemolysis and spherocytosis Most commonly idiopathic, but can be secondary to lymphoproliferative diseases or other autoimmune diseases. Classified according to the optimal temperature at which antibodies bind to RBCs in vitro: 1. Warm AHA – IgG mediated; optimal binding 37 degrees => Treated with steroids or immunosuppresants +/- splenectomy 2. Cold AHA – IgM mediated; optimal binding below 4 degrees => Often associated with raynaud’s => Treated with cold-avoidance +/- chlorambucil
88
Drug-induced Haemolysis
Penicillin-based drugs can cause formation of RBC antibodies Drugs such as quinine cause production of immune complexes
89
Microangiopathic Anaemia
= Mechanical haemolysis caused by physical trauma in the circulation, due to: - Malignant HTN / pre-eclampsia - Haemolytic Uraemic syndrome - Thrombotic thrombocytopaenic purpura - Vasculitis (e.g. SLE) - DIC - Mechanical heart valves The blood film will show schistocytes irregular, asymmetrical cells).
90
Alloimmune Reactions/Haemolysis
Transplant/transfusion/rhesus reactions Immune-mediated, yet Coomb’s negative.
91
Types of WBC and their purpose
NEUTROPHILS – ingest and kill bacteria, fungi & cellular debris LYMPHOCYTES – produce antibodies for cell-mediated immunity. EOSINOPHILS – play a role in allergic reactions and defence against parasitic infection. MONOCYTES – precursor of tissue macrophages BASOPHILS – release histamine in inflammatory reactions
92
Neutrophilia - causes
Bacterial infection Inflammatory reactions Disseminated malignancy Stress – e.g. surgery, burns Myeloproliferative conditions Corticosteroid therapy.
93
Neutropaenia - causes
Viral infections Severe sepsis Neutrophil antibodies – e.g. SLE Bone marrow failure Hypersplenism – e.g. Felty’s Cytotoxic drugs
94
Agranulocytosis
= A complete absence of circulating neutrophils Can be caused by drugs such as carbimazole/clozapine/etc.
95
Lymphocytosis - causes
Viral infections Chronic infections (TB, hepatitis) Myeloproliferative conditions
96
Lymphopaenia - causes
Bone marrow failure Corticosteroid therapy SLE Uraemia HIV Infection Cytotoxic drugs
97
What is Disseminated Intravascular Coagulation (DIC)?
Systemic activation of the coagulation pathways, leading to extensive intravascular coagulation and fibrin clot development. There is thrombotic occlusion of the arterial microvasculature The simultaneous depletion of clotting factors and consumption of platelets leads to haemorrhage. Eventually organ failure develops.
98
Causes of DIC
Infection Trauma Malignancy Obstetric complications (amniotic fluid emboli, pre-eclampsia) Severe liver failure Tissue destruction (pancreatitis/ burns) Toxic / immunogenic stimuli
99
DIC - clinical features
Bruising Excessive bleeding from any sites Renal failure
100
DIC - Ix
Low platelets, low fibrinogen Raised PT & APTT Raised D-dimer Blood-film – broken RBCs (schistocytes)
101
DIC - Tx
Treat the cause Aggressive resuscitation, replacing platelets, coagulation factors (FFP) and fibrinogen (cryoprecipitate). Protein C – reduces mortality in multi-organ failure / severe sepsis.
102
Haematopoiesis
The haematopoietic stem cell first divides into the common myeloid or lymphoid progenitor cell. COMMON MYELOID PROGENITOR cell then subdivides to form - Erythrocytes - Mast cell - Megakaryocytes (go on to form platelets) - Myeloblasts (go on to form monocytes, basophils, neutrophils, and eosinophils) COMMON LYMPHOID PROGENITOR cell subdivides to form: - NK cells - T and B lymphocytes
103
Acute Lymphoblastic Leukaemia (ALL)
= Malignancy of lymphoid cells (of either B or T cell lineages), leading to uncontrolled proliferation of immature blast cells. Leads to eventual bone marrow failure and tissue infiltration Most common malignancy of childhood; it is rare in adults (“L for little”) More common in certain genetic syndromes – e.g. Down’s
104
Prognosis of ALL
Prognosis is good in children under 10 Poor prognosis suggested by: - older age of presentation, - male sex, - B-cell disease, - presence of Philadelphia chromosome (9:22 translocation).
105
Acute Myeloid Leukaemia (AML)
= Malignancy of blast cells from the marrow myeloid elements. It can arise de novo, or on a background of myeloproliferative conditions/ previous chemotherapy/ ionising radiation/ genetic syndromes. Can occur at any age (median age of presentation = 65 years) – “M for mature”
106
AML - prognosis
Rapidly progressive => Only 20% 3-year survival after chemotherapy.
107
Acute leukaemias - presentation
Regardless of subtype, acute leukaemias generally present with: B-symptoms => Fatigue, weight loss, night sweats, fevers, pruritis Bone pain from marrow infiltration Symptoms related to bone marrow failure => Anaemia (SoB on exertion, weakness) => Leucopaenia** (recurrent infections) => Thrombocytopaenia – bleeding/bruising (more common in AML) Hepatomegaly/ splenomegaly. ** Although presenting with leucocytosis, the cells are immature and non-functioning blast cells, thus symptoms of leucopaenia are seen.
108
Acute leukaemias - Ix
FBC Blood film => Blasts are diagnostic => Lineage identified morphologically and confirmed with immunophenotyping CXR – T-cell ALL classically shows mediastinal widening Bone marrow aspiration – to confirm diagnosis and confirm lineage. PET scanning – to check for metastatic disease U&Es, LFTs and cardiac function testing (ECG/ echo) are essential for planning therapy.
109
Acute leukaemias - general Mx
Supportive care: - Barrier nursing - Hickman line for venous access - High-calorie diet - Frequent blood and platelet transfusions - Allopurinol to prevent tumour lysis syndrome due to chemotherapy. - Check frequent bloods and observations for sign of infection Antibiotics => If temperature is >38oC on 2 occasions greater than an hour apart, assume sepsis and start broad spectrum ABX until afebrile for 72 hours.
110
ALL - Management
High-dose chemotherapy to induce remission => Then 2 years of maintenance therapy Consider marrow transplant if poor prognosis or relapse. Transplant is necessary to cure those with the Philadelphia chromosome
111
AML - Management
Intensive chemotherapy In disease with poor prognosis – allogenic marrow transplant from HLA-matched siblings is indicated after the first round of chemotherapy. => This then allows further high-dose chemotherapy In intermediate prognosis disease, autologous marrow transplants may be used (cells grown from own bone marrow) => Further chemotherapy must be at lower doses.
112
Chronic Myeloid Leukaemia (CML) - presentation
Rare in childhood, most common in people age 40-60 Philadelphia chromosome is present in 95% with CML Symptoms: - 30% are detected by chance - Insidious B symptoms are the most common presentation - Gout, due to purine breakdown - Abdominal discomfort due to splenic enlargement O/E: - Massive splenomegaly / hepatomegaly - Signs of anaemia/thrombocytopaenia.
113
CML - Ix
FBC => WCC very high (raised across whole spectrum of myeloid cells) Blood film – spectrum of myeloid cells Bone marrow biopsy – hypercellular CT/PET Cytogenic analysis of blood/marrow for Philadelphia chromosome.
114
CML - Mx
Imatinib chemotherapy is 1st line Stem cell transplant is the only treatment that may achieve remission, but carries significant mortality/morbidity.
115
CML - prognosis
Median survival 6 years. There are 3 phases: 1. Chronic phase – few symptoms, lasts for years 2. Accelerated phase – increasing symptoms, difficulty controlling counts 3. Blast transformation – features of acute leukaemia, eventual death.
116
Chronic Lymphocytic Leukaemia (CLL) - pathophysiology and presentation
= Most common leukaemia Median age at presentation = 70 years. Accumulation of mature B-cells that have escaped apoptosis, and this increasing mass of immune-incompetent cells leads to bone marrow failure. Presentation: - Often asymptomatic, found on routine FBC - May be anaemia or infection-prone - If severe, there can be B-symptoms O/E: - Enlarged non-tender lymph nodes - Hepatosplenomegaly
117
CLL - Ix
FBC - Markedly raised lymphocytes - May be signs of bone marrow failure - Autoimmune haemolysis develops later Blood film – predominant SMUDGE cells (small mature lymphocytes).
118
CLL - Mx
Without treatment: - 1/3rd never progress - 1/3rd will eventually progress - 1/3rd actively progress from diagnosis. Treatment is thus only indicated if symptomatic, or there are cytogenic markers of poor prognosis. Treatment can be with chemotherapy or radiotherapy.
119
CLL - prognosis
prognosis depends on Rai stage (stage 0 - 4) Death is usually due to infection, or transformation to an aggressive lymphoma (Richter’s syndrome).
120
Phaeochromocytoma
= catecholamine secreting tumours, arising from sympathetic paraganglionic cells (known as chromaffin cells).
121
PCC - location
usually located in adrenal medulla 10% are extra-adrenal 10% are bilateral 10% are familial => MEN 2a/2b => Neurofibromatosis => Von Hippel-Lindau Syndrome
122
PCC - presentation
Usually severe/episodic HTN, unresponsive to medical treatment. Also often vague episodic symptoms: - General – sweating, heat intolerance, pallor or flushing - Neurological – headaches, visual disturbances, seizures - CV – palpitations, chest tightness, dyspnoea, postural hypertension - GI – abdominal pain, nausea, constipation Symptoms may be worsened by stress, exercise or drugs.
123
PCC - diagnosis
3x 24-hour urine collections for raised free metadrenaline and nor-metadrenaline. MRI/CT/functional imaging to locate the tumour
124
PCC - Mx
Alpha blockade with phenoxybenzamine. Beta-blockers AFTER alpha blockade is established => Used if significant tachycardia remains after alpha blockade. Surgical excision
125
What is important to remember with using beta-blockers in phaeochromocytoma?
Should only be initiated after alpha-blockade. => can induce life-threatening hypertensive episodes in patients without adequate alpha blockade.
126
What is Addison's disease?
= Primary Adrenal Insufficiency Destruction of the entire adrenal cortex, leading to deficiencies in: 1. Glucocorticoid (cortisol) 2. Mineralocorticoid (aldosterone) 3. Sex steroids
127
How does Addison's differ from hypothalamic-pituitary-adrenal disease?
HPA disease generally spares mineralocorticoid production, which is stimulated by ATII.
128
Causes of Addison's disease
- Autoimmune (most common in UK) - TB (most common worldwide) - Overwhelming sepsis - Metastatic cancer – lung/breast - Lymphoma - Adrenal Haemorrhage (Waterhouse-Friedrichsen syndrome)
129
Addison's disease - presentation
Symptoms: - Often vague and non-specific - Weight loss, malaise, weakness, myalgia - Syncope - Depression Signs: - Pigmentation, especially of new scars and palmar creases. - Postural hypotension - Signs of dehydration - Loss of body hair (particularly axillary/pubic)
130
Addison's disease - Investigations
Bloods: - U&Es – low sodium, high potassium (due to mineralocorticoid insufficiency). - Calcium – raised - Glucose – low, due to lack of cortisol Short ACTH stimulation test / Synacthen Test - Measure plasma cortisol before, and 30 mins after. - A 2nd value >550nmol/L excludes Addison’s 9am ACTH/cortisol => Raised ACTH and low/normal cortisol confirms Addison’s Investigations for cause: - 21-hydroxylase adrenal autoantibodies – autoimmune - CXR – TB - Adrenal CT – to look for TB/metastatic disease
131
How is a Short ACTH stimulation test / Synacthen Test performed?
- Give tetracosactide IM (ACTH analogue). - Measure plasma cortisol before, and 30 mins after. - A 2nd value >550nmol/L excludes Addison’s
132
Addison's Disease - Mx
Long-term glucocorticoid cover: => 15-25mg HYDROCORTISONE daily, in 3 divided doses (mimic diurnal variation) => Avoid giving late in the day, as can cause insomnia. Long-term mineralocorticoid cover: => Required if postural hypotension => FLUDROCORTISONE 50-200 micrograms daily. Patient education: - Steroids should never be abruptly stopped - Extra doses of steroid are needed for strenuous exercise, surgery, febrile illness, or trauma. - Patient should have a steroid card/bracelet and should carry IM hydrocortisone in case of Addisonian Crisis.
133
Addisonian Crisis
Severely inadequate levels of cortisol, occurring either as a first presentation of adrenal disease or triggered by physiological stress. Presents with: - Fever, N&V - Shock - Hypoglycaemia - Hyponatraemia and hyperkalaemia Treat with IV fluids and IV hydrocortisone as part of resuscitation.
134
What is Congenital Adrenal Hyperplasia?
Due to congenital deficiency in 21-alpha-hydroxylase => This enzyme is necessary for the production of mineralocorticoids and glucocorticoids (but not sex hormones) Autosomal recessive. Aldosterone and cortisol levels decrease, and thus ACTH rises. => Precursors such as progesterone build-up and go down the alternative pathway to form sex hormones => testosterone levels raised
135
CAH - presentation
Virilisation of the external genitalia in females => Clitoral hypertrophy (resembling a penis) and variable fusion of the labia (resembling a scrotum). Enlarged penis and pigmented scrotum is seen in males (but rarely noticed). Presents with salt-losing crisis in 80% of males at 1-3 weeks of age (failure to thrive, and potentially fatal hypovolemia and shock) In the non-salt-losing males, presents as hyper-virilisation (early pubarche, adult body odour, muscular build).
136
CAH - Investigations
17-alpha-hydroxyprogesterone levels = markedly raised => this is diagnostic Other features may be: - Low sodium - High potassium - Metabolic acidosis
137
CAH - Mx
Steroid cover, as per Addison’s disease. Also at risk of Addisonian crisis.
138
What is Conn's Syndrome?
Adrenal adenoma, leading to primary hyperaldosteronism Most common in young females. Hyperaldosteronism leads to sodium and water retention.
139
Conn's syndrome - presentation
Mostly asymptomatic HTN (resistant to Tx) Features of hypokalaemia (Cramps, weakness, tetany, polyuria)
140
Conn's syndrome - Investigations
Biochemical features: => Hypernatraemia, Hypokalaemia => Elevated plasma aldosterone:renin ratio => Plasma aldosterone levels will not be suppressed by fludrocortisone administration. Further Investigations: => Once primary hyperaldosteronism is confirmed, adrenal CT is indicated => Adrenal scintography is alternative method (Unilateral uptake of the isotope in Conn’s)
141
Conn's - Mx
Laparoscopic adrenalectomy to remove adenoma Spironolactone pre-op to control HTN/hypokalaemia.
142
RFs for DVT
= anything causing blood stasis or hypercoagulability - Age/immobility - Pregnancy/OCP - Malignancy - Obesity - Surgery (typically occur 2 weeks post-surgery) - Previous DVT
143
DVT - presentation
Most DVTs are silent Classical Clinical features: - Calf tenderness & firmness - Oedema - Erythema & calor - Distension of superficial veins - Superficial thrombophlebitis Atypical Presentation: - Ilio-femoral thrombosis can present with severe pain, but few physical signs. - Complete occlusion of a large vein can lead to cyanotic discolouration.
144
DVT - Ix
Calculate Well’s Score – by risk stratifying to low risk (Wells’ Score <2) and a negative d-dimer the clinician can exclude the need for ultrasound (US) to rule out DVT. D-dimer = Highly sensitive, not specific for DVT (also increased in infection, pregnancy, malignancy, post-op etc.) => If pre-test probability is low and D-dimer is negative – can r/o DVT => If D-Dimer is positive or high/intermediate pre-test probability, do compression USS. Compression USS: => Non-collapsing veins indicate presence of DVTs Thrombophilia screen => Ensure this is done prior to commencing anticoagulant therapy if there are no pre-disposing factors.
145
Preventing post-surgical DVT
Stop COCP 4 weeks pre-op Mobilise as early as possible Immobile patients should be heparinised At risk patients should have TEDs/intermittent pneumatic pressure until 16 hours post-op.
146
Treating proven DVT
LMWH to prevent propagation of the clot Warfarin started simultaneously => LMWH can be stopped when INR = 2-3 Length of warfarin treatment: - 3 months for post-op DVT - 6 months if there was no precipitating cause - Lifelong if known thrombophilia/recurrent DVT
147
PE - presentation
Classically present with: - Sudden-onset breathlessness - Pleuritic pain - Haemoptysis However, PE should be included in almost any respiratory differential as they are so common and variable in presentation. Possible Signs: - Evidence of a DVT - Raised JVP - Cyanosis if embolus is large
148
Massive PE
~5% of PEs >60% of the pulmonary circulation is blocked Leads to rapid cardiovascular collapse
149
Major PE
~10% of PEs Middle-sized pulmonary arteries are blocked Leads to breathlessness, pleuritic chest pain and haemoptysis
150
Minor PE
~85% of PEs Small peripheral vessels are blocked Patients may be asymptomatic or classical presentation. Massive PE may ensue following minor PE (known as premonitory embolus)
151
PE - Investigations
FBC, U&E, clotting, D-dimer ABG – T1RF CXR => Often normal -> May see dilated pulmonary artery or wedge-shaped opacities ECG: => Tachycardia, RBBB, RV strain => Classical SIQIIITIII is rare Echo: => Can confirm right heart strain CTPA = gold-standard => V/Q if this is unavailable, but less accurate
152
SI QIII TIII ECG pattern
Large S wave in lead I Q-wave in lead III T wave inversion in lead III Rare; but sometimes seen in PE (sign of right-heart strain)
153
PE - Management
Major/minor PE should be managed as per DVT. Massive PE: - Emergency A-E resuscitation - IV morphine + antiemetic - Heparin therapy – LMWH/UH If SBP >90mmHg – commence anticoagulant therapy If SBP <90mmHg – start vasopressors (noradrenaline) before commencing thrombolytic therapy.
154
Causes of CKD
* Diabetes mellitus (20-40%) * HTN * Chronic glomerulonephritis * Chronic pyelonephritis * Obstructive uropathy * Renovascular disease * Drugs (e.g. long-term NSAIDs) * PKD
155
CKD - symptoms
Often asymptomatic until very advanced – may be some vague fatigue and anorexia. - Polyuria/nocturia - Restless leg syndrome - Sexual dysfunction - Nausea & Pruritis (early uraemia) - Yellow pigmentation, encephalopathy and pericarditis (severe uraemia) - Pedal oedema & pulmonary oedema.
156
CKD - signs
- Pallor – due to anaemia - Excoriations – due to pruritis - Hypertension/fluid overload signs - Pericardial rub (rare) - Proteinuria
157
Diagnosis of CKD
diagnosed when any two tests, 3 months apart show reduced eGFR and can be stages 1-5 depending on the level of reduction. (in some situations a 24-hour urinary creatinine may be collected to calculate true creatinine clearance)
158
CKD Stage 1
eGFR >90 Normal eGFR but urine findings/structural abnormalities/ genetic traits suggest CKD. Asymptomatic
159
CKD Stage 2
GFR 60-89 Mildly reduced eGFR and other findings (as for stage 1) point to CKD Asymptomatic
160
CKD Stage 3A
eGFR 45-59 = Moderate CKD Usually asymptomatic
161
CKD Stage 3B
eGFR 30-44 = Moderate – severe CKD Pts are often anaemic
162
CKD Stage 4
eGFR 15-29 = Severe CKD Symptoms often at eGFR <20 Electrolyte disturbances
163
CKD Stage 5
eGFR <15 / dialysis = End-stage renal failure (ESRF) Significant complications and symptoms Dialysis usually at eGFR <10
164
CKD - Investigations
Bloods: => FBC, U&Es, LFTs, calcium, phosphate, PTH levels, Glucose Urinalysis: - Any blood? - Quantify proteinuria - Exclude infection - May do 24-hour urinary protein / creatinine clearance - To assess severity / for nephrotic syndrome CXR – ?pulmonary oedema. ECG – if hyperkalaemia Renal USS: - To exclude obstruction - Can look for polycystic kidneys Further Ix: - Renal biopsy – if cause unclear - Renal DTPA scan – investigate vascular supply - Bone imaging – screen for renal bone disease
165
CKD - Management
Treat reversible causes – e.g. obstruction, nephrotoxic drugs 1st line = BP control/diabetic control => BP controlled to <130/80 => If proteinuric, BP <125/75 (ACEi 1st line) Primary CV prevention is also important (statin and low-dose aspirin) 2nd line = control of complications => Recombinant EPO for anaemia => Calcium/vitamin D supplementation for bone disease => K+ restriction for hyperkalaemia Renal replacement therapy is indicated in those with ESRD = dialysis or transplantation => Any symptomatic CKD stage 5 patient
166
Complications of CKD
Renal Anaemia Renal Bone disease Secondary HTN Electrolyte disturbances Myopathy Peripheral neuropathy Increased risk of infection GI – Anorexia, N&V Pericarditis Depression is common – particularly in later stages/dialysis
167
Renal Anaemia
In CKD, the kidney partly loses its secretory EPO function, leading to anaemia. => Correlates with the severity of renal disease Recombinant EPO can be given to those on dialysis with ESRD as part of renal replacement therapy to combat this anaemia Target Hb 100-120
168
Renal Bone Disease - cause - investigation results - treatment
In CKD the kidneys produce less 1-alpha-hydroxylase and excrete less phosphate => low VitD, low Calcium, hyperparathyroidism => Ultimately osteopaenia and osteoporosis Tx: - Restriction of dietary phosphate, - Phosphate binders (calcichew) - AdCal (calcium and vitD supplementation).
169
Indications for Renal Replacement Therapy
ESRF is not a clear cut line, and RRT may be required at different levels in different individuals, but general indications are: A intractable acidosis E electrolyte disturbance (hyperkalaemia, hyponatraemia, hypercalcaemia) I Intoxicants O intractable fluid overload U uraemia symptoms
170
Haemodialysis
Diffusion of solutes between blood and dialysate, which flow in opposite directions with a semi-permeable membrane between. Vascular access is most commonly achieved by: 1. AVF (at the wrist / cubital fossa) 2. Double lumen arterial lines (vascath / permcath) Dialysis must occur for 4 hours, three times weekly. - Normally occurs at hospital - Home treatment is available, but requires support and training in dialysis unit. The main issue is haemodynamic instability during dialysis
171
How is Peritoneal Dialysis performed? What is the main risk?
Continuous ambulatory peritoneal dialysis patients instil up to 2 litres of isotonic/ hypertonic solution into the peritoneal cavity. This then equilibrates with the blood in peritoneal capillaries. The fluid is then drained out after 2 hours. This is performed 3-4 times daily at home Main risk is peritonitis
172
Which is preferable - haemodialysis or peritoneal dialysis?
There is no difference in clinical outcomes between peritoneal and haemodialysis.
173
Renal Transplantation - process and prognosis
Patient assessment: - Virology / TB status – active infection is a CI due to risks of immunosuppression - Blood group / HLA matching - Full systemic examination – comorbid disease is a CI. Prognosis is good => 1 year graft survival rate of 90-95% depending on extent of HLA match
174
Complications of kidney transplant
Operative – bleed, thrombosis, infection, urinary leaks. Rejection – risk highest in 1st 3 months; need lifelong immunosuppression Ciclosporin / Tacrolimus toxicity Infection / malignancy due to immunosuppression (typically skin cancer, anal cancer, lymphoma).
175
Kidney anatomy
Lie in the retroperitoneum of the abdomen. Typically extend from T12 to L3. => The right kidney is generally lower than the left due to the liver. The kidney parenchyma consists of two main regions, covered with a fibrous capsule: 1. inner medulla 2. outer cortex
176
Components of nephron and their function
RENAL CORPUSCLE - site of initial filtration PCT - reabsorption of ions and solutes; regulation of pH by secreting bicarbonate LOOP OF HENLE - Ascending limb aims to create a strong osmotic gradient for absorption of large amounts of water from the descending limb DCT - Secretion of ions, acids, drugs and toxins; Variable reabsorption of water/sodium under the control of aldosterone. COLLECTING DUCT - Variable reabsorption of water under the control of ADH
177
Renin-Aldosterone-Angiotensin System
The juxtaglomerular cells of the kidneys are stretch receptors: 1. Decrease in blood volume => reduced stretch 2. Leads to the release of renin. 3. Renin is involved in the cleavage of angiotensinogen to form AI 4. AI undergoes conversion by ACE to form AII Angiotensin II causes: - Vasoconstriction (of afferent arteriole) => BP increases until it returns to normal - Release of aldosterone from the adrenal cortex => Enhances reabsorption of sodium and water (and increases secretion of K+ and H+), thereby increasing blood volume.
178
Causes of hyperkalaemia
Pseudo-hyperkalaemia (Haemolysis, Incorrect order of blood draw, Sample taken from drip arm) AKI / CKD Drugs: => Supplements, K+-sparing diuretics, ACEis, NSAIDs Acidosis (including DKA) Addison’s disease Tumour-lysis syndrome Burns
179
Symptoms of hyperkalaemia
Often asymptomatic if mild/moderate Muscle weakness, numbness, tingling, N&V Palpitations (=> arrythmias if untreated)
180
Hyperkalaemia - Ix
Raised K+ on U&Es / blood gas ECG signs: - Tall, peaked T waves - Widened QRS complexes - Flattened P-waves / prolonged P-R interval If it goes untreated, ventricular fibrillation / tachycardia can develop.
181
Hyperkalaemia - aims of Tx
Aims of Tx: 1. Stabilise the Heart – Calcium Gluconate 2. Drive potassium intracellularly – insulin & dextrose / salbutamol 3. Tackle the underlying issue to reduce total body potassium
182
Hyperkalaemia - Mx
If potassium >6.5 mmol/L or there are ECG changes, initiate emergency management: 1. Start continuous ECG monitoring 2. 10ml of 10% Calcium gluconate IV to stabilise the heart => Repeat at 5 min intervals until a max of 3 doses or ECG normal 3. 50ml 50% glucose with 10 units Actrapid Insulin into a large vein over 30 minutes to decrease K+ concentration => Onset 1-4 hours, consider BM 4. Consider 10mg Salbutamol neb 5. If pH <7.2, consider sodium bicarbonate IV (if advised by renal registrar) 6. Recheck K+ after 2 hours 7. Consider potassium binders 8. Ensure the underlying cause is being treated.
183
What is AKI?
= a sudden deterioration in kidney function occurring over hours or days, as measured by serum urea and creatinine. This results in a failure to maintain fluid, electrolyte and acid-base homeostasis. Can be PRE-RENAL, RENAL or POST-RENAL
184
Pre-renal AKI
Occurs when renal perfusion is interrupted Main causes: 1. Shock – hypovolaemic, cardiogenic, distributive. 2. Renovascular obstruction: - AAA, - Renal artery stenosis (and ACEis given in bilateral renal artery stenosis), - Renal vein thrombosis If interruption in the blood supply is prolonged, there will be acute tubular necrosis (ATN)
185
Post-Renal AKI
Occurs when there is obstruction of the urinary tract Blockage is often in the ureters – e.g. stones, strictures, clots, external/internal malignancy. Can also be due to bladder outlet obstruction – e.g. prostatic enlargement, urethral strictures, paraphimosis.
186
Intrinsic/ Renal AKI
If there is no pre-renal or post-renal cause of AKI, then intrinsic cause should be suspected Injury or damage to the renal parenchyma, by 3 mechanisms: 1. Acute Tubular Injury (85%) 2. Interstitial Nephritis (10%) 3. Glomerular Disease (5%)
187
AKI - acute tubular injury
Renal causes are due to drugs/toxins damaging the tubular cells (rather than ischaemia, which is pre-renal). Drugs – aminoglycosides, cephalosporins, radiological contrast mediums, NSAIDs. Toxins – heavy metal poisoning, myoglobinuria, haemolytic uraemic syndrome (HUS).
188
Myoglobinuria
Follows an episode of rhabdomyolysis (muscle breakdown from trauma, strenuous exercise or medications), releasing myoglobin which is readily filtered by the glomerulus. Gives the classical dark urine, but in high quantities will precipitate out within the tubules to cause damage. Causes ACUTE TUBULAR INJURY & thus AKI
189
haemolytic uraemic syndrome
Occurs in children following diarrhoeal illness caused by verotoxin-producing E. coli O157, or following a URTI in adults. Thrombocytopaenia, haemolysis and ACUTE TUBULAR INJURY (=> AKI). Children recover within a few weeks, prognosis for adults is poor. Treatment is supportive, including dialysis.
190
AKI - Interstitial Nephritis
Damage is not limited to tubular cells (as in ATN) and bypasses the basement membrane to cause damage to the interstitium. Most commonly caused by drugs (especially antibiotics, but also diuretics, NSAIDs allopurinol and PPIs). Can be caused by infection, auto-immune mechanism or lymphoma. Normally responds to withdrawal of the drugs and a short course of oral steroids.
191
AKI - Glomerular Disease
Glomerulonephritis, thrombosis, HUS, IgA nephropathy
192
AKI - Presentation
Symptoms: - Reduced urine output - Nausea and vomiting - Dehydration - Confusion - Fatigue Signs - Dependent on the underlying cause – look for: - Fluid overload - Hypotension in pre-renal causes, HTN in CKD - Palpable abdominal mass - Associated features of vasculitis – petechiae, skin changes, bruising, etc.
193
Approach to patient with reduced urine output / raised creatinine / decreased GFR
1. Is it AKI or CKD? => Suspect CKD if history of comorbidities (HTN, DM) and long duration of Sx (confirm with USS showing small kidneys) 2. If it is AKI, is it pre-renal / renal / post-renal? => Pre-renal – look for signs of shock and treat appropriately; listen for renal bruits and take vascular Hx => Post-renal – order abdominal or KUB USS; examine prostate in older males. => Renal – drug history, Hx of recent infections / joint pains/ rashes; urine dip (?blood / protein); any red cell casts on microscopy
194
Diagnosis of AKI
NICE recommends using any of the following criteria: 1. A rise of serum creatinine >26 micromol/L in 48 hours 2. A 50% or greater rise in serum creatinine over the past 7 days 3. A fall in urine output to <0.5mL/kg/hour for > 6 hours
195
AKI Stage 1
SERUM CREATININE 150-200% increase OR >25 micromol/L increase in 48h URINE OUTPUT <0.5 mL/kg/hour for 6h
196
AKI Stage 2
SERUM CREATININE 200-300% increase URINE OUTPUT <0.5 mL/kg/hour for 12h
197
AKI Stage 3
SERUM CREATININE >300% increase OR >350 micromol/L increase in 48h URINE OUTPUT <0.3 mL/kg/h for 24h OR Anuria for 12h
198
How should oliguria/anuria be confirmed in patients with suspected AKI?
In order to confirm oliguria/anuria, the patient first needs to be volume replaced to ensure they are euvolaemic.
199
AKI - Investigations
BEDSIDE Urine dip and MC&S Observations Glucose ECG – ?hyperkalaemia BLOODS FBC, U&E, LFTs, clotting, CRP ABG/VBG – ?acid-base imbalance Nephritic Screen if cause unclear Creatine Kinase (if indicated) IMAGING Renal USS to rule out obstruction CXR if pulmonary oedema CT KUB if obstruction
200
Nephritic Screen
ANCA & anti-GBM – Rapidly progressive glomerulonephritis (RPGN) ANA, dsDNA & complement – SLE Immunoglobulins, serum electrophoresis – myeloma Rheumatoid Factor – RA-associated GN Hepatitis B/C screen – Mesangiocapillary glomerulonephritis (MCGN) ASO – post-streptococcal
201
AKI - Management
A – E assessment (with correction of any hypoxia) Hold any potentially damaging drugs Restrict potassium intake Then manage cause: PRE-RENAL = Treat shock RENAL = Assess fluid status Volume replacement (normal saline) to match losses (fluid balance chart) If there is urine output after fluid replacement, continue large quantities of fluid +/- diuretics – furosemide stress test If there is no urine output / there are complications – nephrologist input POST-RENAL = Refer to urology
202
AKI - complications
Hyperkalaemia Hypernatraemia (unless pre-renal cause) Metabolic acidosis Rapidly progressive Uraemia Volume overload => pulmonary oedema CKD and End-stage renal disease
203
What is lymphoedema?
= swelling which results from an increased quantity of fluid in the interstitial space of soft tissues, due to failure of lymphatic drainage. Can be PRIMARY or SECONDARY It causes chronic, non-pitting oedema – commonly affecting the legs and progressing with age
204
Primary lymphoedema
Presents in early life Due to an inherited deficiency of lymphatic vessels (e.g. Milroy’s disease)
205
Secondary Lymphoedema
Due to obstruction of lymphatic vessels (e.g. filarial infection, repeated cellulitis, malignancy, post-op).
206
Lymphoedema - Ix
Lymphoscintography can be used to confirm diagnosis, after other causes of oedema have been excluded (CCF, renal disease, deep venous insufficiency).
207
Lymphoedema - Mx
Elevation Compression stockings Physical massage Long-term ABX if recurrent cellulitis (each episode further damages lymphatic drainage).
208
Raynaud’s Phenomenon vs Raunaud's Syndrome
Phenomenon = general term describing episodic digital vasospasm in the absence of an identifiable associated disorder. Syndrome = Raynaud’s phenomenon occurring secondary to another condition
209
Secondary causes of Raynaud's
Connective Tissue Disease : - Systemic Sclerosis - Mixed connective tissue disease - SLE - Sjogren’s syndrome - Polyarteritis Nodosa Macrovascular Disease: - Atherosclerosis - Thoracic Outlet Obstruction - Buerger’s disease Occupational Trauma - Vibration white finger - Repeated extreme cold or chemical exposure Drugs - Beta-blockers - Cytotoxic drugs Others - Malignancy - AVF
210
Raynaud's - presentation
Common triggers = cold exposure or emotional stress. There are 3 phases: 1. Pallor – due to digital artery spasm 2. Cyanosis – due to accumulation of deoxygenated blood 3. Rubor – erythema due to reactive hyperaemia. As the fingers return to normal, there may be numbness or a burning sensation and severe pain. Attacks are usually <45 minutes; but can last for hours. => Very severe cases can involve tissue infarction and loss of digits.
211
Raynaud's - Investigations
Primary Raynaud’s does not require further investigation. if any features suggesting secondary cause: - FBC, U&E, coagulation, glucose - TFTs - ANA/RF/APA – autoimmune screen if suspecting secondary cause.
212
Raynaud's - Management
Keep extremities warm Smoking cessation Stop exacerbating drugs – e.g. beta-blockers, OCP 1st line medical therapy = nifedipine => Losartan/prazosin/fluoxetine = 2nd line Sympathectomy may help those with severe disease, but may be short lived.
213
Paracetamol overdose - pathophysiology
Paracetamol = intrinsic hepatotoxin - It is conjugated with glucuronide and sulphate at therapeutic doses. - A small amount is metabolised by mixed function oxidase systems to form NAPQI - NAPQI is immediately conjugated with glutathione due to its toxicity. - In overdose, the normal conjugation pathways become saturated - Large amounts of NAPQI are created. - This overwhelms the liver glutathione stores to cause cellular damage. Severity is dose-related, however those who are malnourished/low weight or with high alcohol intake appear to be more susceptible.
214
Paracetamol overdose - Presentation
Most remain asymptomatic for 24 hours – or at most develop anorexia, nausea and vomiting. Symptoms/signs start to develop after 24 hours: - RUQ pain - Metabolic acidosis - Hypotension - Hypoglycaemia - Pancreatitis - Arrythmias Liver damage is not detectable on blood tests until 18 hours after ingestion. => Damage peaks at 72-96 hours post-ingestion (deranged ALT/ALP and INR) Without Tx, some develop fulminant liver failure. Renal failure due to acute tubular necrosis can also occur.
215
Paracetamol overdose - Tx
A-E approach Lavage if >12g (>150mg/kg) taken within 1 hour. Give activated charcoal if <1 hour since ingestion. Take a full set of bloods at 4 hours post ingestion - Including INR, ABG, LFTs, U&Es, glucose, blood salicylate and paracetamol level If <8 hours after ingestion – give IV acetylcysteine if blood levels above the treatment line on the hospital protocol. If >8 hours after ingestion – treat immediately with N-acetylcysteine if >150mg/kg has been ingested. => Discontinue if plasma levels return below the treatment line, and the patient is asymptomatic with normal biochemistry. If the patient continues to deteriorate then discuss with the liver team. Discharge only after mental health team review.
216
Why is paracetamol level not measured until 4 hours after overdose ingestion?
Paracetamol level is unreliable before the 4-hour mark due to continuing absorption/distribution
217
N-acetylcysteine
Replenishes cellular glutathione stores and may repair oxidative damage. Potential SEs: - Rash, oedema, hypotension, bronchospasm (rarely serious; treated with IV chlorphenamine). - Only stop the infusion in true anaphylaxis
218
Causes of splenomegaly
Infection => E.g. IE, bacterial sepsis, EBV, TB, malaria, schistosomiasis. Inflammation => E.g. RA, SLE, sarcoidosis Portal HTN Haematological disease => Haemolytic anaemia, leukaemia, lymphoma, myeloproliferative disorders -- MASSIVE splenomegaly (palpable in the RIF) can be seen in myelofibrosis, CML, lymphoma, malaria, leishmaniasis or Gaucher’s disease.
219
Hypersplenism
Splenomegaly of any cause can lead to hypersplenism, which results in: 1. Pancytopaenia 2. Increased plasma volume 3. Haemolysis
220
What is the function of the spleen?
= largest lymphoid organ in the body functions to break down erythrocytes and for immunological defence
221
Splenic Rupture
Most commonly caused by blunt trauma, occasionally by penetrating injuries. Pre-existing illness can markedly increase the risks of splenic injury Presentation: - Immediate massive bleeding - Peritonism from progressive blood loss - Eventually shock Rupture can occur hours-days after the initial trauma, due to expanding haematoma beneath the capsule (asymptomatic interval).
222
3 main routes of bacterial infection of the liver
1. Ascending spread from cholangitis 2. Portal spread from a focus of sepsis in the abdomen 3. Systemic bloodstream spread in septicaemia
223
Pyogenic Liver Abscess - cause and presentation
Most common organisms: - E. coli - Strep. Milleri - Anaerobes Presentation: - Patients are often not acutely unwell, may just have a long history of malaise. - Can present acutely unwell with abdominal sepsis and a tender enlarged liver. - May be pleural effusion in the right lower chest.
224
Pyogenic Liver Abscess - Investigations
USS/CT can detect a liver abscess. CXR may show elevation of the right hemidiaphragm +/- pleural effusion
225
Pyogenic Liver Abscess - Management
Aspiration under USS guidance. IV ABX Treat underlying cause
226
Amoebic Liver Abscess - causes and presentation
Consider in patients with a Hx of travel. Faeco-oral spread of entamoeba histolytica. Presentation: - May be asymptomatic - Can get profuse/bloody diarrhoea - Swinging high fever, RUQ pain and tenderness
227
Amoebic Liver Abscess - Investigations
Stool microscopy will show offending organism, blood and pus. USS/CT to visualise the abscess
228
Amoebic Liver Abscess - Mx
Metronidazole for 5 days = Tx for amoebic dysentery USS drainage may also be required.
229
Liver Hyatid Cyst - cause and presentation
Caused by echinococcus granulosis (dog tapeworm). Infects humans coming into contact with infected dogs or food/water contaminated with dog faeces. Thick-walled, slow-growing cyst Either Asymptomatic or dull ache in RUQ
230
Liver Hyatid Cyst - Investigations
Positive hyatid complement fixation test/haemagglutination, eosiniphilia. AXR – may show calcification of cyst wall USS/CT – shows cyst
231
Liver Hyatid Cyst - Management
Albendazole and FNA under USS guidance Deworming of pet dogs.
232
Liver Mets
90% of liver tumours are secondary metastases. Primaries commonly in the lung/stomach/colon/breast/uterus. Management = investigation to find the primary
233
Hepatocellular Carcinoma - causes
= Malignant tumour of hepatocytes – accounts for the majority of primary liver cancers. Common in China and Sub-Saharan Africa (rare in the west) Causes: - Chronic hepatitis / cirrhosis - Metabolic liver diseases - Aspergillus aflatoxin - Parasites - Anabolic steroids
234
Hepatocellular Carcinoma - presentation
Symptoms: - Non-specific fever, malaise, weight loss. - RUQ pain Signs: - Hepatomegaly (may be smooth or hard/irregular) - Signs of chronic liver disease / decompensation - Abdominal mass / bruit over liver - Jaundice is late presentation
235
Hepatocellular Carcinoma - Ix
Bloods – FBC, LFTs, clotting, hepatitis serology, AFP (raised in >50% of HCC) USS/CT to identify lesions and guide biopsy MRI to distinguish between benign/malignant lesions ERCP/biopsy if cholangiocarcinoma suspected
236
Hepatocellular Carcinoma - Mx
Surgery for solitary HCCs <3cm, but high risk of recurrence Liver transplantation if there are small tumours due to cirrhosis => Resection in cirrhosis can lead to decompensation
237
Benign liver tumours
Most commonly haemangiomas (incidental finding on CT/USS) If the patient is a young woman on the OCP, it may be more likely to be a liver cell adenoma. A benign liver tumour should only be treated if large/symptomatic
238
Jaundice
= yellow discolouration of the sclera, skin and mucous membranes secondary to hyperbilirubinaemia Generally, the bilirubin needs to be around 2x the upper limit to be clinically visible
239
Bilirubin Metabolism
1. Bilirubin is a product of haemoglobin breakdown. When a red cell is broken down (typically in the spleen), this releases unconjugated bilirubin (UCB). 2. UCB is binds to albumin before being transported to the hepatocytes of the liver. 3. In the liver it is conjugated by a hepatic enzyme. This conjugated bilirubin (CB) is then stored in the gallbladder as part of bile. 4. Bile is released during digestion, where the CB is then broken down in the small intestine into Urobilinogen. 5. Urobilinogen then takes 1 of 3 paths: - Converted to stercobilin in the gut and excreted in the stool - Absorbed into blood before being excreted by the kidney in the urine. - Recycled back to the liver to be re-excreted in bile.
240
Stercobilin and Urobilinogen
Stercobilin gives stools their dark colour Urobilinogen in the urine is oxidised to urobilin when exposed to air, eventually giving the urine a dark colour (as opposed to immediate dark urine of cholestasis, which is caused by conjugated bilirubin).
241
What are the 3 sub-types of jaundice?
1. Pre-hepatic – Increased RBC breakdown 2. Hepatic – Dysfunction of hepatocytes 3. Post-hepatic – Cholestasis due to obstruction
242
Pre-hepatic Jaundice
Occurs due to increased breakdown of RBCs leads to increased UCB – this overwhelms the capacity of the hepatocytes to conjugate it There will be leftover UCB in the bloodstream and results in jaundice. Causes = anything causing haemolysis.
243
Hepatic Jaundice - causes
Hepatitis (Viral, autoimmune, alcoholic) Cirrhosis Drug-induced liver injury Wilson’s Disease Jaundice occurs due to: 1. UCB not conjugated at a sufficient rate, leading to increased circulating UCB. 2. A degree of obstruction means that CB not being transported into biliary ducts, CB builds up in the hepatocytes and ends up in the bloodstream (increased circulating CB).
244
ISOLATED unconjugated hyperbilirubinaemia
= hyperbilirubinaemia with no other blood test abnormalities (i.e. LFTs and reticulocytes) DUE TO GILBERT'S SYNDROME
245
Gilbert's Syndrome
Autosomal recessive inherited condition Leads to defective gene encoding for the hepatic conjugation enzyme. Intermittent jaundice in the absence of haemolysis or underlying liver disease. Will see isolated elevated UCB on investigation => Normal LFTs and reticulocytes Benign and self-limiting condition
246
Hepatic Jaundice - stool/urine colour
Urinary urobilinogen may be raised (due to inability of the liver to re-excrete what is reabsorbed) If conjugated bilirubin levels are high enough => dark urine. Stools could be paler than usual (due to a decrease in the ability to conjugate bilirubin and excrete it into the gut)
247
Pre-hepatic Jaundice - stool/urine colour
Large amounts of bilirubin excreted into the gut => normal stools Urinary urobilinogen also raised (but no clinically dark urine as takes time to oxidise). UCB cannot be excreted in urine
248
Post-hepatic jaundice - causes
Due to obstruction of bile outflow from the liver – leading to cholestasis. Obstruction can be INTRA or EXTRA-HEPATIC => Pressure backs up bile between hepatocytes back to vasculature and CB is pushed back into the bloodstream (conjugated hyperbilirubinaemia).
249
Causes of intra-hepatic bile outflow obstruction
Hepatitis Cirrhosis Neoplasm Drugs (chlorpromazine, flucloxacillin, isoniazid, OCP) Pregnancy
250
Causes of extra-hepatic bile outflow obstruction
Gallstones Cholangiocarcinoma Primary sclerosing cholangitis Congenital atresia of CBD Pancreatitis Tumour of pancreatic head
251
Post-hepatic jaundice - stool/urine colour
Pale stools – very little/no bilirubin reaching the GI tract. Dark urine – conjugated bilirubin reaches the kidneys through the blood.
252
Jaundice - Investigations
Bloods: => FBC, reticulocytes, LFTs, U&Es, clotting, glucose, bilirubin levels. Urinary urobilinogen/bilirubin Further Investigations: - Blood films / Coomb’s test – if ?haemolysis - Viral serology/autoantibodies – if ?hepatitis - USS - ?dilated duct system - CT/MRI - intrahepatic / pancreatic lesions ERCP if ductal system dilated on USS
253
Acute causes of hepatitis
Viral infections (Hep A-E or non-Hep infections) Autoimmune Drug reactions Alcohol
254
Chronic causes of hepatitis
Hepatitis B +/- D virus Hepatitis C virus Autoimmune hepatitis Alcohol Hyperlipidaemia (NAFLD) Drugs (methyldopa, nitrofurantoin) Metabolic disorders (Wilson’s, alpha1-antitrypsin deficiency, haemochromatosis)
255
Liver screen
Done in any patient with suspected hepatitis / liver pathology of unknown origin Microbiology – viral screen Clinical chemistry: - Ferritin / transferrin - Lipids - Caeruloplasmin - AFP - Alpha-1 antitrypsin Immunology – autoantibodies Abdominal USS
256
Hepatitis A
Transmitted faeco-orally Notifiable disease Does not lead to chronic liver disease, thus there are no carriers. No specific treatment
257
Hepatitis E
Transmitted faeco-orally Clinically similar to HepA infection: - Causing epidemics of acute, self-limiting hepatitis - No progression to chronic disease Common in indo-china, so consider if recent travel. Can cause severe disease in pregnant women
258
Which hepatitis viruses are spread faeco-orally ?
A E
259
Hepatitis B
transmitted in blood/semen/saliva via skin breaks or mucous membranes Vertical transmission = common worldwide Around 10% of those infected will develop chronic disease 1% will develop fulminant liver disease
260
Which hepatitis viruses are spread via bodily fluids?
B C D
261
RFs for hepatitis B infection
Unprotected sex with multiple partners / someone who is infected Sharing needles MSM Living with someone with chronic HBV Infant born to infected mother Job that exposes you to human blood Travel to regions with high infection rates of HBV, such as Asia, the Pacific Islands, Africa and Eastern Europe
262
Hepatitis D
= Incomplete RNA virus Can only cause infection in the presence of Hep B (as it requires the HepB virus for its own assembly). Also transmitted by bodily fluids Can be both acute and chronic It can be acquired simultaneously with Hep B, or occur later. Patients with Hep D superadded to HepB infection are more likely to develop fulminant liver disease.
263
Hepatitis C
clinically similar to HepB infection Transmitted via bodily fluids Particularly common in IVDUs Vertical transmission is rare, and sexual transmission is uncommon About 85% become chronically infected 30% get cirrhosis in 20 years.
264
Pathophysiology of Acute Hepatitis
Pathological changes are the same, regardless of cause. Hepatocytes undergo degenerative changes (swelling & vacuolation) before necrosis and rapid removal. Extent can vary from scattered necrosis to multiacinar necrosis leading to fulminant hepatic failure.
265
Pathophysiology of chronic hepatitis
= Defined as any hepatitis lasting more than 6 months. Chronic inflammatory cell infiltrates are present in the portal tracts. There may be loss of definition, necrosis and fibrosis. This eventually leads to cirrhosis The overall severity is judged by the degree of inflammation (grading) and the extend of fibrosis/cirrhosis (staging). => Using various scoring systems such as the Child-Pugh Score.
266
HBsAg Hep B surface Antigen
Marker of viral replication and thus ACTIVE infection. Appears within 6 weeks of infection Disappears by 3 months after
267
HBsAb Anti-HepB surface antibody
Marker of previously cleared infection OR vaccination
268
HBeAg Hep B E Antigen
Marker of a high degree of viral replication (infectivity)
269
HBeAb Anti-HepB E Antibody
Marker of natural immunity to Hep B
270
HBcAb IgG Anti-HepB core IgG Antibody
Non-specific marker of current / previous infection
271
HBcAb IgM Anti-HepB core IgM Antibody
Infection within the last 6 months
272
Hep B Virus PCR
= The best marker of viraemia
273
Immune tolerance phase (i.e. incubation) of hep B
HBsAg / HBeAg & PCR positive Liver Transaminases negative (transaminases will be raised in any active disease)
274
Evidence of Hep B vaccination
Vaccination involves injecting the hepatitis B surface antigen. Therefore there should only be evidence of surface antigen immunity (HBsAb)
275
Acute Viral Hepatitis - Presentation
PRE-ICTERIC PHASE: - 1-2 week prodrome – malaise, arthralgia, headache, anorexia - Classic aversion to cigarette smoke - Vague RUQ pain ICTERIC PHASE: - Patient becomes jaundiced – with associated pale stools and dark urine (intrahepatic cholestatic jaundice) - Pruritis - May be associated with lymphadenopathy and hepato-splenomegaly. Hep A and C often cause very mild or no symptoms Extra-hepatic features are more common in Hep B
276
Acute Alcoholic Hepatitis - Presentation
Presents after a binge with jaundice, RUQ pain and systemic upset. May be signs of chronic liver disease (acute on chronic presentation) Bilirubin, prothrombin time and hepatic encephalopathy predict survival (combined to form the “discriminant function”) AST:ALT ratio >2.0 suggests alcoholic liver disease.
277
Autoimmune Hepatitis - presentation
Most commonly presents as chronic hepatitis, but up to 40% of patients get acute hepatitis with jaundice. The chronic form presents insidiously: - Generally in women with non-specific symptoms of fatigue, arthralgia, fevers and weight loss. Age peaks are at 15-25 or perimenopausal years. Associated with other autoimmune conditions - Most commonly primary biliary cirrhosis - Primary sclerosing cholangitis - IBD
278
Autoimmune hepatitis - Ix
High transaminases and IgG levels Negative viral serology High tires of autoantibodies (non specific – e.g. ANA) Final diagnosis is with a liver biopsy.
279
Presentation of chronic hepatitis
Often asymptomatic unless complications (e.g. cirrhosis) develop Can only be diagnosed when serum ALT levels are elevated for >6 months => E.g. on follow-up from acute viral hepatitis diagnosis.
280
Autoimmune Hepatitis - Mx
Start prednisolone 30mg OD Add Azathioprine 1mg/kg/day after TPMT assays If there are falls in transaminases, gradually reduce the prednisolone dose to maintain the fall. Long-term therapy with low-dose prednisolone (5-10mg) and azathioprine is then recommended => Bone protection plus monitoring required
281
Hepatitis B - Mx
Have a low threshold for screening patients with RFs for acquiring HBV Notify Public Health (it is a notifiable disease) Refer to gastroenterology, hepatology or infectious diseases for specialist management Lifestyle: - Stop smoking and alcohol - Education about reducing transmission and informing potential at risk contacts The acute episode is treated with supportive therapy and alcohol avoidance (95% will recover and develop immunity) 1st line management of chronic hepatitis is with SC peginterferon alfa-2a for 48 weeks.
282
Hepatitis C - Mx
Very specialist area of management – Refer to gastroenterology, hepatology or infectious diseases There are new drugs on the market that have replaced PEG interferons
283
Indications for liver biopsy
- Chronic hepatitis - Cirrhosis - Suspected neoplastic disease - Storage diseases - Unexplained hepatomegaly
284
Liver biopsy - contraindications
- Prolonged PT - Platelet count <80 - Ascites - Extrahepatic cholestasis
285
Alternatives to liver biopsy
A newer alternative = fibroscan (transient elastography), which allows the liver “stiffness” to be measured non-invasively. Other non-invasive tests exist = MR elastography, serum biomarker tests.
286
Spirometry - FEV1
= volume that has been exhaled at the end of the 1st second of forced expiration (Typically, over 70-80% of the FVC will be expired in the first second)
287
Spirometry - FVC
= forced vital capacity; the volume that has been exhaled after a maximal expiration following a full inspiration. (usually around 5L)
288
Spirometry - TV
= Tidal Volume; the volume of air entering and leaving the lung with each normal breath
289
Spirometry - Kco / TLco
Both measures of gas transfer KCO = Diffusion capacity of the lung per unit area for CO. TLCO = Diffusion capacity of the total lung capacity for CO. Decreased TLCO /KCO indicate an issue with gas exchange, which can be due to either ALVEOLAR disease or VASCULAR disease. => This rules out chest wall/ diaphragm pathology.
290
Spirometry - obstructive pattern
Normal (or increased FVC) Reduced FEV1/FVC
291
Spirometry - restrictive pattern
Reduced FVC Normal (or increased) FEV1/FVC
292
What is bronchiectasis?
= chronic dilation of the airways, leading to chronic inflammation/infection.
293
Bronchiectasis - presentation
SYMPTOMS: * Recurrent cough, with copious amounts of infected sputum. * Intermittent haemoptysis (can be the only symptom). * Persistent halitosis * Dyspnoea * Recurrent febrile episodes and episodes of pneumonia SIGNS * Clubbing * Coarse inspiratory crackles over infected areas (typically bibasal) * Wheeze * Often low BMI, due to high energy demands
294
Bronchiectasis - causes
Idiopathic = most common Otherwise: - Post-infective – TB, measles, pertussis, pneumonia - CF - Bronchial obstruction – tumour/FB - Allergic broncho-pulmonary aspergillosis - Ciliary dyskinetic syndromes – Kartagener’s syndrome, Young’s syndrome - Immune deficiency – IgA, hypogammaglobulinaemia - CTDs – 1/3rd of RA patients develop bronchiectasis.
295
Bronchiectasis - Pathophysiology
Any bronchi may be involved, but most commonly at the lung bases. Airways are dilated, with purulent secretions and chronic inflammation in the wall with inflammatory granulation tissue => Granulation tissue can bleed, leading to haemoptysis. With repeated exacerbations, there can be fibrous scarring, leading to respiratory failure.
296
Bronchiectasis - Ix
Sputum culture => Atypical organisms CXR - Cystic shadowing CT => To assess distribution of disease; => Can see dilated airways with “signet ring” sign. Spirometry => Obstructive pattern => Reversibility should be assessed. Other tests to look for cause => E.g. serum immunoglobulins, CF sweat test, aspergillus precipitins
297
What organisms are often seen in bronchiectasis
Atypical organisms Most common organism is haemophilus Pseudomonas, Klebsiella and Strep pneumoniae are also common
298
Bronchiectasis - Mx
Assess for rare but treatable causes (e.g. immune deficiencies) Smoking cessation Chest Physiotherapy => Inspiratory muscle training Postural drainage – twice daily ABX for exacerbations => According to known sensitivities => Constant rotating ABX in severe disease Immunisations Bronchodilators can be useful in some cases Surgery is rarely indicated (as the disease is rarely confined to one lobe). => Lobectomy used to be common
299
Indications for Lobectomy
Lung cancer Previously Bronchiectasis (less common now) Chronic lung abscess / TB Fungal infections – life-threatening haemoptysis due to aspergillus.
300
Sarcoidosis
= Systemic non-caseating granulomatous disease. Most commonly affects the lungs, mediastinal lymph nodes, and skin. Typically occurs in females, aged 20-40 Presents as subacute illness, with non-specific features of malaise, arthralgia, etc. Pulmonary manifestations lead to fibrosis. Sarcoidosis can also lead to glomerulonephritis, cardiomyopathy, arthritis, cranial nerve lesions and erythema nodosum.
301
Sarcoidosis - Mx
The acute form is usually self-limiting (2 months to 2 years) but it can present as a chronic insidious disease, with progressive dyspnoea. Tx: - Simple analgesia and NSAIDs - Occasional corticosteroid courses if there is progressive lung fibrosis.
302
How can aspergillus fungus affect the lungs?
1. Asthma 2. Extrinsic Allergic Alveolitis (EAA) – malt worker’s lung 3. Allergic Bronchopulmonary aspergillosis 4. Aspergilloma 5. Invasive Aspergillosis
303
Allergic Bronchopulmonary aspergillosis
More common in asthmatics and CF patients Type I and II reaction, giving asthma-like symptoms with a productive cough Needs steroid Tx
304
Aspergilloma
= fungal ball formation within pre-existing lung cavities (e.g. TB) May be asymptomatic, cause general malaise/weight loss or torrential haemoptysis. Tx = Single lesions may be resected.
305
Invasive Aspergillosis
Affects immunocompromised individuals Needs aggressive Tx with antifungals Mortality is high
306
Cystic Fibrosis - inheritance
Autosomal recessive inheritance Caucasians have a carrier frequency of 1 in 25 Due to a mutation in the cystic fibrosis transmembrane conductance regulator (CTFR) gene on chromosome 7, position 508. Genetic screening is available for the 4 most common mutations, and this identifies 90% of CF cases.
307
What is the most common mutation causing CF?
point deletion (DF508) This codes for a cAMP-regulated chloride cannel present on multiple epithelial surfaces (predominantly in the pancreas and respiratory tract).
308
CF - pathophysiology
mutation in the CTFR gene leads to abnormally thick secretions, this leading to pancreatic insufficiency and recurrent chest infections.
309
CF - pulmonary effects
Recurrent childhood chest infections FTT Breathlessness and haemoptysis develop in later years as progressive bronchiectasis develops. Spontaneous PTX is common Most will have chronic sinusitis and many will have nasal polyps Respiratory failure and cor pulmonale can eventually develop due to scarring of the pulmonary vasculature.
310
Pathogens involved in chest infections in CF
initially mainly caused by S. aureus, Haemophilus influenza and gram-negative bacilli. Later, pseudomonas predominates (this is associated with poor prognosis).
311
CF - GI effects
Meconium ileus is common at birth Steatorrhoea due to pancreatic dysfunction, associated with malabsorption Increased frequency of gallstones & peptic ulceration. Cirrhosis sometimes develops in older patients.
312
CF - other effects (non-GI/pulmonary)
Clubbing Infertility in most males (congenital absence of vas deferens rather than increased viscosity) Subfertility in females DM Rickets/osteomalacia (due to vitD deficiency)
313
CF - Ix
Bloods: - FBC, U&Es, LFTs, clotting Sodium sweat test - Levels >70 mmol/L are characteristic Annual diabetes screening Sputum cultures CXR => Hyperinflation, evidence of bronchiectasis. Abdo USS => Fatty liver/cirrhosis => Chronic pancreatitis Spirometry => Obstructive deficits
314
CF - Mx
CHEST - Two parenteral ABX are used for exacerbations (to decrease resistance, often one with pseudomonal cover). - Experts may decide whether to employ regular ABX prophylaxis - Mucolytics (e.g DNase daily nebulisers) - Airway clearance devices (E.g. acapella) - Lung transplant (if resp. failure develops). GI - Pancreatic enzyme replacement (Creon) - Fat soluble vitamin supplementation (ADEK) - Liver transplantation for advanced cirrhosis OTHER - Tx of diabetes - Fertility treatment - Genetic counselling. + disease modifying drugs?
315
Disease modifying drugs in CF
Orkambi: - Used for patients with homozygous DF508 - Lumacaftor increases the number of CFTR proteins transported to the cell surface - Ivacaftor potentiates those already at the cell surface to increase the probability that the channel will be open Symkevi: - Can also be used for heterozygous DF508 patients.
316
Bundle Branch Block
In BBB, the depolarisation wave reaches the septum normally, so the PR interval is normal (in contrast to complete heart block). Delayed depolarisation of the ventricles thus leads to wide QRS (>120ms or 3 small squares)
317
Right Bundle Branch Block
The septum is depolarised from the left side as normal As it takes longer for excitation to reach the right ventricle, this depolarises after the left, causing a second R wave. RBBB is best seen in V1 with an "RSR pattern" Delayed overall conduction time to the RV extends the QRS duration to > 120 ms No specific Tx is needed for RBBB, but consider underlying ASD / PE.
318
Left Bundle Branch Block
conduction delay means that impulses travel first via the right bundle branch to the RV, and then to the LV via the septum Delayed overall conduction time to the LV extends the QRS duration to > 120 ms The overall depolarisation vector from the right to left ventricle produces tall R waves in lateral leads (I, V5-6) and deep S waves in the right precordial leads (V1-3). The delay between activation of the RV and LV produces the characteristic "M-shaped" R wave seen in lateral leads -- If LBBB is present, no further interpretation of the ECG is possible. => If asymptomatic, consider aortic stenosis. => If chest pain, LBBB = STEMI as you cannot prove otherwise
319
What is heart block?
= abnormal conduction from the SAN to the ventricles.
320
1st Degree Heart block
= Fixed, prolonged PR-interval (>5 small squares or 1 big square) The prolongation remains fixed in length, and P-waves remain associated with QRS complexes 1st degree Heart Block is not itself pathological, but it can indicate: - Coronary artery disease - Acute rheumatic fever - Electrolyte disturbances - Digoxin toxicity.
321
2nd Degree Heart Block – Mobitz I (Wenckebach)
Excitation intermittently fails to pass through the AVN or bundle of His. PR-interval progressively elongates, eventually culminating in the non-conduction of one P-wave, before the cycle begins again with a minimally-prolonged/normal PR interval. Often no specific treatment needed for this type.
322
2nd Degree Heart Block – Mobitz II (Hay)
Excitation intermittently fails to pass through the AVN or bundle of His. Intermittent conduction and non-conduction of P waves without PR-interval prolongation (can be no pattern, or fixed ratio e.g. “2:1”, “3:1”, etc. ) This type of block will need permanent pacing due to high risk of asystole.
323
3rd Degree Heart Block
= complete heart block There will be total dissociation between atrial and ventricular activity => NO conduction between atria and ventricles => ventricles are excited by a slow escape mechanism randomly Can occur acutely following MI, or be a chronic state. Tx --> Pacing is generally always required due to high risk of asystole.
324
Sinus arrythmia
Occurs in young people where heart rate changes with respiration – R-R interval changes progressively on a beat-beat basis.
325
Sinus Bradycardia
HR <60 Can be associated with athletic training, fainting attacks, hypothermia, hypothyroidism. Can also occur immediately after MI
326
Sinus tachycardia
HR >100 Can be associated with exercise, fear, pain, haemorrhage or thyrotoxicosis
327
supraventricular rhythms
QRS complex is normal – depolarisation spreads to the ventricles in the usual way via the bundles. Sinus rhythms give a normal P wave Atrial rhythms give an abnormal P wave Junctional rhythms (AVN) will not show P waves.
328
Ventricular rhythms
wide (slower spread of depolarisation through the ventricles) and abnormal QRS complexes.
329
Ventricular escape rhythm
A slow, protective rhythm initiated by a focus in the ventricles if the SAN fails or conduction is completely blocked ~20 - 40 bpm
330
Bradycardia - Mx
A-E, treat reversible causes Assess for adverse features and risk of asystole => Adverse features – shock, syncope, heart failure, myocardial ischaemia => Risk of asystole – recent asystole, Mobitz II or complete heart block If none of these features are present, continue to observe and monitor. If any of these features are present, initiate treatment and seek expert help => Atropine 500 mcg IV; repeated up to a maximum of 3mg. Cardiology may then initiate transcutaneous pacing prior to more definitive pacing of the heart.
331
Extrasystoles
If any part of the heart depolarises quicker than it should, and this is accompanied by an extra heartbeat, this is called an extrasystole. Atrial extrasystoles have an abnormal P wave Junctional extrasystoles have no P wave => Normal QRS complexes in both Ventricular extrasystoles have a wide QRS that can take virtually any shape. These are common and usually of no importance, however, if they occur early in the T wave of a preceding beat, they can induce a ventricular fibrillation.
332
What is Supraventricular Tachycardia?
the atria depolarise faster than 150/min => P waves are often superimposed on the previous T waves. The AV node can only conduct atrial discharge rates of up to 200/min, so above this “atrioventricular block” occurs and some P waves are not followed by QRS complexes.
333
Supraventricular tachycardia - Mx
A-E resuscitation, asses for adverse features. => Synchronised DC cardioversion if any adverse features. If irregular rhythm / atrial flutter – treat as AF If regular, first attempt vagal manoeuvres: => Carotid sinus massage / Valsalva manoeuvre => These lead to vagal stimulation of the SAN/AVN, causing decreased SAN discharge and increased AVN delay. If unsuccessful, IV adenosine. => 6mg initially, 12mg if no effect, then another 12 mg bolus. Electrical cardioversion if this is not successful. Secondary prevention is indicated with beta-blockers
334
Vagal manoeuvres in SVT
Carotid sinus massage / Valsalva manoeuvre => These lead to vagal stimulation of the SAN/AVN, causing decreased SAN discharge and increased AVN delay.
335
Ventricular tachycardia
Wide, abnormal QRS seen in all 12 leads. Potential to transform to VF, so requires urgent treatment Management: - If systolic BP <90mmHg, chest pain, heart failure or rate >150 – immediate electrical cardioversion - If absence of these signs – amiodarone 300mg loading dose over 30 minutes => Electrical cardioversion if this fails
336
Ventricular fibrillation
No QRS can be identified and the ECG is totally disorganised The patient will usually have lost consciousness Manage as per the cardiac arrest protocol.
337
Atrial Fibrillation
Irregular baseline with no P waves The AVN is bombarded and thus will depolarise irregularly, leading to ventricular contraction at an irregular rate. => Usually 450-600 atrial contractions / minute => Normal QRS as conduction from the AVN is not abnormal AF can be asymptomatic, or present with dyspnoea, palpitations, syncope, chest pain or stroke / TIA If no abnormalities are seen on ECG, 24-hour ambulatory ECG monitoring or an event recorder can be used to detect paroxysmal AF.
338
AF - management
If presenting symptomatic with haemodynamic instability – emergency electrical cardioversion and immediate anticoagulation. If haemodynamically stable: 1. Rate control 2. Rhythm control 3. Anticoagulation
339
AF management - rate control
Generally 1st line Beta-blocker (bisoprolol) or RL CCB (verapamil / diltiazem) are the agents used. => CCBs are CI’d in heart failure; => Beta-blockers are CI’d in asthma Therapeutic target is 60-80 bpm at rest If the symptoms are not controlled with one drug, combination therapy can be used.
340
AF management - rhythm control
May be indicated in younger patients with new onset AF (<48h) and evidence of a reversible cause (e.g. chest infection), or the AF is causing heart failure. Cardioversion can be pharmacological or electrical Pharmacological options include flecanide and amiodarone. Cardiologist referral is generally required.
341
AF management - anticoagulation
Heparin at initial presentation (if no contraindications / not already anti-coagulated) Then assessment of the need for long-term anticoagulation using the CHA2Ds2VAsc tool to assess stroke risk => Anticoagulation should be considered for anybody with a score of 2 or more => The HASBLED tool should be used to assess the risk of major bleeding. Either warfarin or a DOAC can be used according to patient preference (target INR 2-3) If an anticoagulant is contraindicated, offer DAPT (aspirin and clopidogrel), as one antiplatelet alone is not sufficient.
342
Causes of AF
Cardiac – HTN, valvular heart disease, heart failure, ischaemic heart disease. Respiratory – chest infections, PE, lung cancer Systemic – excessive alcohol intake, thyrotoxicosis, electrolyte depletion, infections, DM. Consider assessment for these with FBC, TFTs, U&Es, glucose, ECG (old infarction), echo and CXR.
343
Atrial Flutter
If the atrial rate is above 250 / min and no flat baseline between P waves exists, atrial flutter is present. => Classic “sawtooth” baseline. Can be thought of as similar to AF, in that the normal coordination of the atria are lost, however some element of synchronicity still exists. Generally treated as per AF.
344
Wolff-Parkinson White Syndrome
Some people have an accessory conduction pathway, causing the action potential to bypass the AVN. This triggers early depolarisation of part of the ventricle (seen as a Delta Wave on the ECG) The second part of the QRS is normal as the bundle of His conduction catches up The ECG s in sinus rhythm but there is right axis deviation, short PR interval and widened QRS with a delta wave of pre-excitation. The only clinical importance is that it can cause paroxysmal tachycardia
345
Right Atrium
Receives deoxygenated venous blood from the SVC, IVC and coronary sinus. Pumps blood though the right atrioventricular orifice (guarded by the tricuspid valve) separates the RA and RV. Forms the right border of the heart.
346
Right Ventricle
Receives deoxygenated blood from the right atrium Pumps blood through the pulmonary orifice (guarded by the pulmonary valve), into the pulmonary artery. It forms the majority of the anterior border of the heart.
347
Left Atrium
Receives oxygenated blood from the four pulmonary veins Pumps blood through the left atrioventricular orifice (guarded by the mitral valve) into the left ventricle The left atrium forms the posterior border (base) of the heart
348
Left Ventricle
Receives oxygenated blood from the left atrium Pumps blood through the aortic orifice (guarded by the aortic valve) into the aorta.
349
Left Coronary Artery
Initially branches to yield the left anterior descending (LAD) artery (also “anterior interventricular artery”) Also gives off the left marginal artery (LMA) and the left circumflex artery (Cx). In ~20-25% of individuals, the left circumflex artery contributes to the posterior interventricular artery (PIv). Typically supplies: - The left atrium - Most of the left ventricle - Part of the right ventricle - Most of the IV septum – usually anterior two thirds (including AV bundle) - The SA node – approx. 40% of people
350
Right Coronary Artery
Branches to form the right marginal artery (RMA) anteriorly. In 80-85% of individuals, it also branches into the posterior interventricular artery (PIv) posteriorly. Typically supplies: - The right atrium - Most of the right ventricle - Part of the left ventricle - Part of the IV septum – usually posterior third - SA Node – approx. 60% of people - AV Node – approx. 80% of people
351
Coronary veins
The coronary sinus runs from left to right in the posterior part of the coronary sulcus. The coronary sinus receives the great cardiac vein at its left end and the middle and small cardiac veins at its right end
352
ECG - P-wave
represents atrial depolarisation Normally <3 small squares
353
ECG - PR interval
= the distance between the start of the P wave and the start of the QRS complex it represents atrial depolaristation and the delay at the AV Node. Normal duration = 3-5 small squares
354
ECG - QRS Complex
represents ventricular depolarisation. Normal duration – <3 small squares Normally positive in I, II, V4-V6; negative in aVR, V1 and V2
355
ECG - QT interval
represents the whole ventricular action potential normal to be slightly longer in women This needs rate-correcting (QTc)
356
approach to ECG interpretation
1. Patient identification + indication for ECG + calibration 2. General Impression 3. Rate 4. Rhythm 5. Axis 6. P-waves (present / absent) 7. P-R Interval (normal / prolonged / shortened) 8. QRS complexes (narrow / broad) 9. ST segments 10. T waves 11. QT Interval
357
ECG - cardiac axis
1. Normal Axis => I, II and III all point up 2. Left axis deviation (“leaving”) => I up, II and III down - often associated with essential hypertension or valvular heart disease 3. Right axis deviation (“reaching”) => I down, II and III up - often associated with COPD and pulmonary hypertension.
358
ECG - ST elevation
Is the J-point of the ST segment elevated? must be by at least: * 1mm in the limb leads * 2mm in the chest leads must occur in 2+ adjacent leads => indicates STEMI
359
ECG - ST depression
Any depression >0.5mm in 2+ leads is abnormal Indicates ischaemia.
360
"tall and tented" T waves
Tall – at least ½ the amplitude of the preceding QRS complex Tented – look as if they’ve been pinched from above - i.e. a pointed peak, narrow base Caused by hyperkalaemia.
361
inverted T waves
This is normal in Lead aVR (where everything should be negative) can be a normal variant in Leads V1 and III T-wave Inversion in other leads is a non-specific sign for Ischaemia, BBBs, PE, Hypertrophic Cardiomyopathy (HCM) etc.
362
flattened T waves
a non-specific sign of ischaemia or of electrolyte imbalance (e.g. Hypokalaemia)
363
polycystic kidney disease - inheritance
Can be either: - autosomal dominant (more common, less severe) - autosomal recessive.
364
Autosomal dominant PKD
Both kidneys are gradually replaced by enlarging fluid-filled cysts, compressing the parenchyma out of existence. Presentation: - Systemic HTN - CKD - Abdominal swelling (due to very large kidneys bilaterally) Renal failure generally occurs later in life, after the genes are passed on. Cysts also occur in the liver, lungs, pancreas (but without symptoms).
365
Autosomal recessive PKD
Rarer Earlier in onset Runs a more malignant course, with chronic renal failure earlier in life. Cysts in the liver lead to portal HTN and fibrosis
366
PKD - Management
As for CKD, but with screening for berry aneurysms.
367
Glomerulus structure
The glomerulus creates three layers for substances to pass through: 1. Fenestrated capillary epithelium 2. Basement membrane 3. Visceral layer – formed by interdigitating podocytes. This creates a “sieve” that allows small, charged ions through, yet will not allow the transport of proteins or blood.
368
Glomerulonephritis - pathophysiology
injury to the glomerulus, caused by an immunological attack, by an antibody or T cell attacking an antigen in the glomerulus. This may be primary or secondary (acquired/deposited) Capillary - Endothelial cell proliferation => bigger fenestra - Capillary wall necrosis - Glomerulosclerosis – scarring in the mesangium leading to fenestra and capillaries being pulled apart. Basement Membrane - Thickened membrane – leading to structural distortion and thus becomes more permeable. Tubules - Deposition of cells in Bowman’s space.
369
Secondary factors causing deposition of antigens in the glomerulus ("NSAID HSP")
N – neoplasm S – SLE A – amyloid I – Infection D – Diabetes HSP – Henoch Schoenlein Purpura
370
Potential histological changes in glomerulonephritis
GLOBAL – whole glomerulus is diseased SEGMENTAL – small patches of one glomerulus are damaged in a “patchy” fashion DIFFUSE – affecting >50% of glomeruli FOCAL – affecting <50% of glomeruli
371
Nephrotic Syndrome - triad of symptoms
1. Proteinuria (at least 3.5 g/day) 2. Hypoalbuminaemia (<30g/L) 3. Oedema (due to decreased oncotic pressure and water retention). => Oedema typically occurs peri-orbitally and peripherally in limbs.
372
Nephrotic Syndrome - Mx
Investigate as per any suspected glomerulonephritis Tx: Diuretics, salt/water restriction and ACEIs to reduce proteinuria Anticoagulation if immobile, due to risk of thrombosis Treat the cause.
373
Nephrotic Syndrome - causes
most common primary causes: - Minimal change nephropathy - Membranous glomerulonephritis - Proliferative glomerulonephritis Secondary causes may be bacterial/viral infection, drugs, neoplasm.
374
How does nephrotic syndrome cause venous thrombosis?
Renal loss of thrombo-regulatory proteins or lipo-regulatory proteins may lead to hyperlipidaemia or venous thrombosis.
375
Nephritic Syndrome - tetrad of symptoms
Tetrad of: 1. Haematuria + red cell casts (can be microscopic) 2. Oliguria 3. Proteinuria (can be less than 3.5g) 4. HTN
376
Is nephrotic or nephritic syndrome proliferative?
NEPHROTIC - non-proliferative NEPHRITIC - proliferative (increased cell numbers as well as damage to the basement membrane)
377
Nephritic syndrome - causes
Common primary causes: - IgA nephropathy - Goodpasture’s disease Secondary causes are commonly SLE/HSP.
378
Glomerulonephritis - Ix
Bloods – FBC, U&E, CRP, culture Urine dip to r/o infection Urine MCS for red cells/red cell casts/ Bence-jones protein Urine protein/creatinine ratio to quantify protein loss. Nephritic screen to look for causes. Renal USS Renal biopsy to confirm the cause in all adults
379
Urine protein:creatinine ratio
generally used instead of 24-hour urinary protein estimation, as it is more convenient and equally accurate. The amount of protein in mg per mmol of creatinine equates to the amount of protein excreted in over 24 hours Random protein:creatinine ratios >300mg/mmol are considered “nephrotic range” Ratios of 50-100 mg/mmol are considered significant proteinuria and should be repeated with an early morning sample.
380
Glomerulonephritis - Buerger’s Disease
= IgA nephropathy presents with nephritic syndrome Renal biopsy demonstrates IgA/C3 deposits Mx: - Supportive - 20% progress to ESRD over 20 years – steroids may slow the decline in renal function.
381
Glomerulonephritis - Minimal Change Nephropathy
The most common cause of glomerulonephritis in children (75%) Characterised by normal light microscopy and negative immunofluorescence Electro-microscopy will show fusion of podocyte foot processes. Tx: - Oral steroids - Cyclophosphamide if relapsing. - 99% of cases resolve in 4-6 weeks if treated with steroids (adults may need longer courses).
382
Glomerulonephritis - Membranous Nephropathy
Mostly idiopathic Diagnosed on biopsy => Global diffuse glomerulonephritis with IgG and C3 deposits
383
Focal Segmental Glomerulosclerosis
Idiopathic areas of segmental sclerosis, with IgM and C3 deposits Response to treatment is poor.
384
Membranoproliferative Glomerulonephritis
Presents with nephrotic or mixed nephrotic / nephritic syndrome Biopsy shows large glomeruli with a “double basement membrane” due to mesangial proliferation, giving a tramline appearance 50% develop ESRF in 10 years, and there is a high recurrence rate in transplants.
385
Post-streptococcal Glomerulonephritis
Patients present with nephritic syndrome 1-2 weeks following a sore throat / skin infection Biopsy shows a diffuse proliferative GN with IgG and C3 deposits, although there is no need to biopsy in typical cases. Bloods: - Raised ASOT / anti DNAase B - Reduced complement levels
386
What is Henoch Schoenlein Purpura (HSP)?
Typically in children aged 3-15 Present with symptoms of a systemic small vessel vasculitis (IgA deposition) and nephritic syndrome following an URTI
387
HSP - Investigations
Diagnosis is usually clinical, confirmed with positive immunofluorescence in skin/renal biopsy (IgA).
388
HSP - presentation
Purpuric rash on extensor surfaces Polyarthritis Abdominal pain (due to GI bleeding) Scrotal/scalp swelling Glomerulonephritis (indistinguishable from IgA nephropathy).
389
HSP - management
Attacks are usually self-limiting If there are relapses/evidence of progressive renal involvement, then corticosteroids are indicated.
390
Goodpasture’s Syndrome
Anti-glomerular basement membrane (anti-GBM) antibodies recognise an epitope on type IV collagen, present in the glomerular basement membrane. Presents with: - Haematuria and a rapidly progressive glomerulonephritis - Pulmonary haemorrhage leading to haemoptysis and breathlessness.
391
Goodpasture's Syndrome - Ix
CXR will show pulmonary shadowing Renal biopsy will show linear IgG deposition along the glomerular basement membrane.
392
Goodpasture's syndrome - Mx
= plasma exchange and corticosteroids +/- cytotoxics.
393
Glomerulonephritis - systemic vasculitis
Leads to focal segmental glomerulonephritis, with appearance overlapping with IgA nephropathy They are often ANCA positive.
394
Rapidly Progressive Glomerulonephritis
= Glomerulonephritis rapidly leading to ESRF, presenting with signs of renal failure and systemic disease. Causes: - Immune complex diseas (e.g. SLE / endocarditis / IgA nephropathy). - Vasculitis (e.g. HSP, Wegener’s, Churg-strauss syndrome, etc.) - Goodpasture’s disease Management: - Aggressive immunosuppression (high dose steroids and cyclophosphamide). - Prognosis depends on how early treatment is initiated.
395
Spinal cord - ascending tracts
The tracts by which sensory information from a peripheral nerve is transmitted to the cerebral cortex. Consists of: - Dorsal columns - Lateral Spinothalamic Tract - Ventral spinothalamic tract
396
Spinothalamic Tracts
Transmit pain, temperature, and light touch to the thalamus. Decussates at the spinal level.
397
Dorsal Columns
Transmit deep touch, proprioception, and vibration to the parietal cortex. Decussates in the brainstem.
398
Corticospinal Tracts
Transmits motor axons from the motor cerebral cortex to the spinal cord. Decussates in the brainstem.
399
General Approach to spinal cord trauma
A to E => High C-spine lesions can lead to a total/partial loss of respiratory function. Determine the mechanism of injury Physical Examination: => Vision, palpation of vertebral column, neurological exam. Imaging
400
Imaging choice in spinal cord trauma
AP / lateral/ C2 open mouth (peg view) XR (if the C-spine cannot be cleared clinically) CT C-spine if - Already having head/other body CT - If X-Rays are suspicious - If intubated/rapid diagnosis required. Whole spinal X-ray if one spinal fracture identified.
401
Spinal trauma - Unconscious Patients
Any trauma patients with LoC need C-spine stabilisation If there are signs of neurological deterioration, urgent CT head to T4/5 should be performed. If there are not – cervical, thoracic and lumbar spine XR is required. Spinal precautions can be ceased if a consultant radiologist reviews the above imaging and there are no signs of an abnormality; as well as no clinical signs suggestive of a spinal cord injury.
402
Spinal trauma - Conscious Patients
If GCS is 15 and the patient is stable, follow the “Canadian C-spine Rules” if spinal injury is a concern. If the patient is >65, has paraesthesia in the extremities or there was a dangerous mechanism => radiography. If not, then there are 5 factors which will allow attempt to clinically clear the C-spine. 1. Simple rear-end RTA 2. Sitting position in ED 3. Walking at any time 4. Delayed onset of neck pain 5. Absence of C-spine tenderness If none of these factors are present, then radiography is required. If one or more of these criteria are satisfied, attempt to clear clinically: * Ask the patient to rotate neck 45o to left and right * If the patient can do this, the C-spine can be considered “cleared” without radiology. If there is clinical uncertainty, it is always better to err on the side of caution and get radiology input.
403
Cord Transection at C3
- Neurogenic shock - Respiratory insufficiency - Quadriplegia - Anaesthesia below affected level - Loss of bladder/bowel sphincter tone - Sexual dysfunction - Horner’s syndrome may also be present
404
Cord Transection at T10
- Paraplegia - Anaesthesia below affected level - Loss of rectal/bladder sphincter tone. - Sexual dysfunction
405
Cord Hemi-section (Brown-Sequard Syndrome)
A unilateral lesion of the spinal cord will cause Brown-Sequard Syndrome: => Ipsilateral reduced power (CST) / vibration & proprioception (DC) => Contralateral reduced pain/temperature/light touch (STT) This can occur in trauma or transverse myelitis (MS)
406
Posterior Cord Lesion (= loss of dorsal tract)
Tingling, numbness, electric-shock like syndromes Clumsiness O/E: - Sensory ataxia - Loss of proprioception, - Loss of vibration sense - Loss of 2-point discrimination below the level of the lesion.
407
Causes of Posterior Cord Lesion
Demyelinating disease – e.g. MS, B12 deficiency, etc. External compression – e.g. tumours, mechanical degeneration of cervical spine. Occlusion of posterior spinal artery.
408
What is normal ICP?
Normal ICP is 0-10 mmHg.
409
Causes of increased ICP
Vasogenic – increased capillary permeability => Tumour, trauma, ischaemia, infection Cytotoxic – cell death Interstitial – obstructive hydrocephalus
410
Raised ICP - symptoms
Headache - Dull persistent ache, - Worse on lying, - Present on waking, - Worse by coughing/straining Vomiting Seizures Irritability
411
Raised ICP - signs
GCS deterioration Progressive dilation of the pupil on the affected side Cushing’s reflex Cheyne-Stokes respiration (Papilloedema is NOT an acute sign of raised ICP, it takes weeks to occur)
412
Raised ICP - Mx
Elevate the head of the bed to 30-40 degrees If intubated, hyperventilate to reduce PaCO2 => Almost immediate reduction in ICP Mannitol => 0.2g/kg 20% IV over 15 minutes => Clinical effect after 20 minutes => Useful as a temporary measure prior to definitive management Corticosteroids: => Only useful for oedema around tumours Fluid restriction Consider monitoring ICP (surgically implanted extradural catheter) Make diagnosis and treat the cause
413
Methods to reduce ICP
Hyperventilation if intubated Mannitol Controlled hypothermia, CSF drainage Barbiturates.
414
Positioning the patient for an LP
The patient lies on their side, curled forward with knees to their chest (opens lumbar interspinous spaces). Alternative position = sitting forward, curled into a pillow (especially useful in obese patients). However, the opening pressure can only be measured if the head is at the same level as the lumbar spine (i.e. in lateral recumbent position).
415
Performing a Lumbar Puncture
The spine of L4 is identified. => Found at the level of the tops of the iliac crest. A LP needle is introduced obliquely above L4, parallel to the place of the spine, though the interspinous ligament. There is a slight “give” as the needle pierces the dura-arachnoid mater to enter the subarachnoid space. The cord has ended, so rare to pierce the dura mater of the cauda equina and cause nerve damage.
416
LP - indications
Diagnosis of meningitis/encephalitis Diagnosis of SAH => If clinically suspected but no abnormalities on CT Measurements of CSF pressure => Idiopathic intracranial HTN Therapeutic removal of CSF: => Idiopathic intracranial HTN Intrathecal drug administration Diagnosis of various conditions: => MS, neurosyphilis, Behcet’s disease
417
LP - complications
Post-LP headache Dry tap (correct position of needle but no CSF comes out) Infection Damage to spinal nerves – causing weakness/paraesthesia Coning of cerebellar tonsils.
418
Post-LP headache
Occurs in 30% Onset within 24 hours, resolution over 2 weeks. Constant bilateral dull ache. Worse when upright Treat with analgesics +/- blood patch (re-injection of the patient’s own blood to form a clot).
419
LP - contraindications
Suspicion of intracranial / spinal cord mass, or raised ICP. => This can lead to coning of the cerebellar tonsils => Any unconscious patient must have a CT prior to LP Overlying/local infection Congenital lesions in the area (e.g. meningomyelocele) Problems with haemostasis Haemodynamic instability.
420
CSF xanthochromia
Xanthochromia = yellow-ish colour of the CSF. Caused by bilirubin from RBC breakdown => RBCs in the CSF indicates there has been a SAH If the RBCs in the CSF are due to bleeding at the LP site, they will not have been degraded to bilirubin, so CSF will not be xanthochromic.
421
CSF findings in MS
Moderately raised protein levels – less than 1 g/L Up to 50 lymphocytes / mm3 Oligoclonal IgG bands on electrophoresis.
422
What is Guillain Barre Syndrome ?
= a rapid-onset muscle weakness caused by the immune system damaging the peripheral nervous system. Thought to be auto-immune process - Symptoms occur 1-3 weeks after an infection - Infection may be trivial and unidentified - Campylobacter and CMV infections are well-recognised causes of severe GBS
423
Guillain Barre Syndrome - Presentation
Ascending paralysis, with loss of tendon reflexes Sensory loss is rare Usually affects the lower limbs initially Ascends and progresses over several days to weeks. Proximal muscle involvement is common – e.g. cranial nerves, respiratory muscles. Other complications: - VTE - Autonomic involvement – leading to BP lability / arrythmias
424
Guillain Barre Syndrome - Diagnosis
Supported by nerve conduction studies (showing slowed conduction) CSF protein is often also raised.
425
Guillain Barre Syndrome - Mx
Severe cases progress rapidly over hours to days. Admit to HDU Some patients will require ventilator support. s.c. Heparin plus TED stockings High dose IV immunoglobulin (IVIG) within the first 2 weeks. => Reduce duration and severity of paralysis => Corticosteroids are of no use.
426
Guillain Barre Syndrome - Prognosis
In mild cases, there is little disability before spontaneous recovery. Complete recovery occurs over months in 80-90% => Some may be left with residual weakness Mortality is very high in the acute phase – up to 10%
427
What is motor neurone disease?
= degenerative disease of UMNs and LMNs in the spinal cord, cranial nerve motor nuclei and the cortex. There is NO sensory involvement. It is sporadic, with the cause unknown (although there are rare genetic forms). Peak onset is age 50-70
428
What are the 4 broad patterns of MND?
Amyotrophic Lateral Sclerosis Progressive Muscular Atrophy Primary Lateral Sclerosis Bulbar Presentation
429
MND Amyotrophic Lateral Sclerosis - presentation
Loss of spinal and brainstem LMNs, and cortical UMNS (giving both UMN and LMN signs) Progressive spastic tetraparesis and added LMN signs such as wasting and fasciculation. May be associated with fronto-temporal dementia Presentation: - LMN weakness – starting in the hands and progressing to upper arms/legs - UMN spastic weakness – starting in the legs and progressing to the arms - Bulbar palsy / pseudobulbar palsy O/E: => The classical sign is muscle wasting and fasciculation with brisk reflexes and up-going plantars. Sensory examination is normal
430
MND Progressive Muscular Atrophy - presentation
Loss restricted to spinal LMNs, giving purely LMN signs Painless wasting begins in the small muscles of the hands, and spreads. O/E – wasting and fasciculation is seen
431
MND Primary Lateral Sclerosis - presentation
Rare form of MND Disease confined to cortical UMNs, giving purely UMN signs Progressive tetraparesis
432
MND - Bulbar Presentation
Bulbar symptoms with preservation of limb function in early stages. Poor prognosis due to early respiratory involvement
433
Guillain Barre Syndrome - diagnosis
Diagnosis can be clinical in the presence of mixed UMN / LMN signs in multiple limbs, but investigations are usually useful to establish the diagnosis: - Bloods – r/o differentials - Spinal cord MRI – r/o myelopathy - EMG – evidence of denervation, can be diagnostic.
434
Guillain Barre Syndrome - Mx
Should be managed by a specialist MDT Social and carer assessments are important Disease modifying therapy: => Riluzole – increases pre-synaptic glutamate release, can increase survival in ALS patients by an average of 3-4 months. Nutritional Support Respiratory Support => Overnight NIPPV if respiratory weakness is an issue (biggest prognostic benefit) Tx of complications (as per MS)
435
MND - prognosis
Remission of MND is not known Death is eventually from bronchopneumonia or ventilatory failure due to weakness of the respiratory muscles.
436
What do LMNs innervate? What are the signs of a LMN lesion?
LMNs innervate ipsilateral muscles Signs: - Weakness - Wasting - Fasciculation - Hypotonia - Hyporeflexia
437
What do UMNs innervate? What are the signs of an UMN lesion?
UMNs innervate contralateral muscles SIGNS: - Weakness (characteristically extensor weakness in UL, flexor weakness in LL) - No wasting - Hypertonia, spasticity - Hyperreflexia - Loss of fine motor movements - Pronator drift - Extensor plantar response - Clonus
438
Causes of LMN lesions
Ventral horn pathology (MND, post-polio) Peripheral nerve pathology NMJ pathology (MG) Muscular pathology
439
Causes of UMN lesions
Vascular – stroke Inflammatory – MS, MND Neoplastic – tumour Degenerative – Parkinson’s Infective – post-meningitis Drugs
440
LMN vs UMN lesions in the face
LMN lesions cause ipsilateral facial weakness of all muscles of facial expression. UMN lesions cause contralateral facial weakness, but spare frontalis (as this received supranuclear innervation from both hemispheres) => Furrowing of the brow, eye closing and blinking are preserved
441
Cerebrum - Frontal lobe
Separated from the parietal lobe posteriorly by the central sulcus and from the temporal lobe infero-posteriorly by the lateral sulcus Responsible for: * Higher intellect, * Personality, * Mood, * Social conduct * Language (dominant hemisphere side only).
442
Cerebrum - Parietal lobe
Between the frontal lobe anteriorly and the occipital lobe posteriorly Separated from these by the central sulcus and parieto-occipital sulcus Contributes to the control of: * Language and calculation on the dominant hemisphere side * Visuospatial functions (e.g. 2-point discrimination) on the non-dominant hemisphere side.
443
Cerebrum - Temporal lobe
Inferior to the frontal and parietal lobes, from which it is separated by the lateral sulcus. Involved with: * Memory * Language – this includes hearing as it is the location of the primary auditory cortex.
444
Cerebrum - Occipital lobe
The most posterior part of the cerebrum Its inferior aspect rests upon the tentorium cerebelli, which segregates the cerebrum from the cerebellum The parieto-occipital sulcus separates the occipital lobe from the parietal and temporal lobes anteriorly. The primary visual cortex (V1) is located within the occipital lobe (hence it is responsible for vision)
445
Cerebellum - location and function
Located at the back of the brain, immediately inferior to the occipital and temporal lobes, and within the posterior cranial fossa. It lies at the same level of and posterior to the pons, (these are separated by the fourth ventricle) Plays an important role in motor control. => In particular – coordination, precision and timing of movements, as well as in motor learning Each cerebellar lobe controls movement of ipsilateral limbs. The vermis (midline structure) maintains midline posture and balance.
446
Anterior Cerebral Artery
Supplies medial surface of cerebral hemisphere, as far back as the peri-occipital sulcus
447
Middle Cerebral Artery
Supplies 2/3rd of the lateral surface of the brain Central branches supply the corpus striatum, thalamus and internal capsule.
448
Posterior Cerebral Artery
Supplies the corpus callosum and cortex of occipital and temporal lobes. Central branches supply the optic radiation, subthalamic nucleus and thalamus
449
What is the blood supply to the brainstem and cerebellum ?
supplied by the vertebral and basilar arteries
450
CN I
= Olfactory Special sensory – smell from nasal mucosa
451
CN II
= Optic Special sensory – vision from retina
452
CN III
= Oculomotor Somatic motor – 4 of 6 extra-ocular muscles, levator palpebrae superioris. Visceral motor – pupil constriction
453
CN IV
= Trochlear Somatic motor – superior oblique muscle
454
CN V
= Trigeminal Ophthalmic nerve (V1) – sensory to upper 1/3rd of face and cornea Maxillary Nerve (V2) – sensory to middle 1/3rd of face Mandibular Nerve (V3): - Sensory – lower 1/3rd of face - Motor – muscles of mastication
455
CN VI
= Abducens Somatic motor – lateral rectus muscle
456
CN VII
= Facial Somatic motor – muscles of facial expression Visceral motor – submandibular/sublingual glands; lacrimal gland Special sensory – taste from the anterior 2/3rd of tongue General sensory – skin of external acoustic meatus.
457
CN VIII
= Vestibulocochlear Special sensory – hearing and balance.
458
CN IX
= Glossopharyngeal Somatic motor – swallowing Visceral motor – parotid gland Special sensory – posterior 1/3rd of tongue General sensory – external ear and pharynx
459
CN X
= Vagus Somatic motor – swallowing Visceral motor – parasympathetic innervation to smooth muscle of trachea, bronchi, GI tract and heart. General sensory – auricle and external acoustic meatus
460
CN XI
= Spinal Accessory Motor – SCM and trapezius muscles
461
CN XII
= Hypoglossal Motor – intrinsic/extrinsic muscles of tongue
462
Which cranial nerves arise from the medulla oblongata?
Also the "bulb" => "bulbar palsy" = CN IX, X, XII
463
What is hydrocephalus?
= excessive CSF within the cranium. High pressure then leads to dilation of the lateral ventricles +/- dilation of the 3rd and 4th ventricles. Can be either COMMUNICATING or NON-COMMUNICATING (or, very rarely, caused by CSF overproduction)
464
Non-communicating Hydrocephalus
Most common type Due to blockage of the CSF pathways from the ventricles to the subarachnoid space.
465
Communicating Hydrocephalus
Due to impairment of CSF reabsorption at the arachnoid vili along the dural venous sinuses. Usually precipitated by infection (particularly TB meningitis) or SAH
466
Risk factors for hydrocephalus
Patients with congenital malformations => E.g. stenosis of the aqueduct of Sylvius. Posterior fossa / brainstem tumours Post brain insult => E.g. SAH, head injury, meningitis
467
Hydrocephalus - presentation
- Headache - Vomiting - Papilloedema - Cognitive Impairment - Ataxia - Bilateral pyramidal signs
468
Hydrocephalus - Ix
CT to assess size of ventricles MRI if suspecting malformations / tumour
469
Hydrocephalus - Mx
MEDICAL = to reduce CSF secretion / increase absorption - Only role is to delay surgical management - Acetazolamide, alone or in combination with Furosemide. SURGICAL: - Ventriculo-atrial or ventriculo-peritoneal shunting for progressive symptoms (Valves open at certain pressures to release CSF) - Endoscopic 3rd ventriculostomy is an alternative procedure for obstructive hydrocephalus. - Neurosurgical removal of tumours if appropriate
470
Normal Pressure Hydrocephalus
= the syndrome of enlarged lateral ventricles usually in the elderly associated with a classic triad: 1. Dementia (despite no signs of cortical atrophy on CT) 2. Urinary incontinence 3. Ataxia
471
Normal Pressure Hydrocephalus - Ix
Isolated CSF measurements are usually normal, but continuous monitoring may show intermittent periods of raised pressure.
472
Normal Pressure Hydrocephalus - Mx
Some patients respond to ventriculoperitoneal shunting, only indicated if they respond to trials of lumbar drainage.
473
What is myasthenia gravis?
= an autoimmune condition that causes muscle weakness that gets progressively worse with activity and improves with rest. Due to IgG autoantibodies against the ACh receptor located on the post-synaptic membrane of the motor end plates
474
myasthenia gravis - pathophysiology
IgG autoantibodies against the ACh receptor located on the post-synaptic membrane of the motor end plates This blocks synaptic transmission at the NMJ and prevents the acetylcholine from being able to stimulate the receptor and trigger muscle contraction These antibodies also activate the complement system within the neuromuscular junction, leading to damage to cells at the postsynaptic membrane. (a small % of MG cases are caused by other antibodies against important proteins for the creation and organisation of the acetylcholine receptor)
475
What can Myasthenia Gravis be associated with?
There is a strong link with thymoma (a tumour of the epithelial cells of the thymus) ~25% with MG have thymoma.
476
Myasthenia Gravis - Presentation
Weakness and fatiguability that gets worse throughout the day. Classically affects: - Proximal limb muscles – fluctuating proximal weakness, more common in the upper limb. - Extra-ocular muscles – symmetrical diplopia and ptosis - Bulbar muscles – dysphagia/speech difficulties - Muscles of facial expression – weakness in facial movements Wasting and respiratory difficulties may occur after many years. The heart is not affected. Tendon reflexes are preserved.
477
Myasthenia Gravis - Ix
Serum anti-AChR antibody titre Single fibre electromyography => Diagnostic – decreased responses to repeated stimulation TFTs and CT – for evidence of thymoma
478
What is an Edrophonium test (Tensilon test)?
Previously used in the diagnosis of MG Now rarely used due to risk of arrythmia IV injection of edrophonium (short-acting anticholinesterase) – will produce rapid, transient improvement in features. Cardiac monitoring and resuscitation should be available.
479
Myasthenia Gravis - Mx
Avoidance of certain antibiotics that may exacerbate NM blockade – e.g. aminoglycosides Lifelong long-acting oral ANTICHOLINESTERASES => Neostigmine/pyridostigmine. CORTICOSTEROIDS for relapses: Starting in hospital, as risk of increasing weakness early on. Weakness of respiratory muscles can be life-threatening => Monitor FVC, May need ventilatory support => Severe cases will require IVIG / plasmapheresis Alternate-day regimen after discharge => Azathioprine may be useful as a steroid-sparing agent. Thymectomy => Performed at any age will increase the chance of remission
480
What % of strokes are haemorrhagic?
~15% of strokes = either intra-cerebral haemorrhage or SAH
481
Intracerebral haemorrhage - presentation
As per haemorrhagic stroke At the bedside there is no reliable way to differentiate. => More likely to present with severe headache and coma
482
Intracerebral Haemorrhage - Ix
CT – haemorrhage will be seen immediately MRI – very reliable after 2 hours from symptom onset.
483
Intracerebral Haemorrhage - Mx
Stop and reverse any anticoagulation Intubate if GCS is 8 or less Lower BP to <140/90 within 1 hour => IV labetalol Maintaining adequate oxygenation and MAP Neurosurgical intervention may be required.
484
SAH - presentation
“Thunderclap” headache => Develops over seconds, devastating intensity, often occipital => Often comes on during times of transient HTN – such as physical activity or sexual intercourse. Vomiting: => Comes on after developing the headache. Photophobia Increasing drowsiness/coma Focal signs may point to the location of the lesion. => However, may just reflect raised ICP (false localising sign) or cerebral vasospasm due to the irritant effect of blood. O/E: - Neck stiffness - Positive Kernig’s sign – takes 6 hours to develop - Papilloedema (may be present); retinal haemorrhages.
485
SAH - “sentinel headache”
The patient may have experienced an earlier “sentinel headache” before the thunderclap headache. due to a small warning lead from the offending aneurysm. Small bleeds may give few physical signs, but almost always a headache.
486
SAH - Predisposing Abnormalities
Berry Aneurysms (70%) Arteriovenous Malformations (10%) No lesion found (20%)
487
Berry Aneurysms - locations
Developmental rather than congenital Develop in circle of Willis and adjacent arteries ACA = most common PCA – at bifurcation from ICA MCA – at bifurcation/trifurcation
488
RFs for berry aneurysms
- Polycystic kidney disease - FHx - Smoking - HTN - Connective tissue diseases
489
PCA berry aneurysm - presentation
MASS EFFECTS => most common cause of painful 3rd CN palsy HAEMORRHAGE
490
SAH - AVMs
Congenital collection of abnormal arteries/veins Have a tendency to rebleed if symptomatic once (10% will rebleed annually) Can also cause epilepsy
491
SAH - complications
DEATH – 30% will die immediately RE-BLEED: => Aneurysms – the initial bleed may be fatal, however if vasospasm is sufficient then a clot can form; this usually holds for 3-4 days before re-bleeding. => AVMs – generally rebleed within a few years. HYDROCEPHALUS: Due to fibrosis in the CSF pathways CEREBRAL VASOSPASM: Can be severe, leading to delayed ischaemic damage.
492
SAH - Ix
Bloods: - FBC, U&E, LFT, ESR, clotting CT = initial Ix of choice - SAH/intraventricular blood usually seen within 48h LP – if CT normal - Should be done >12 hours after symptom onset - CSF will be xanthochromic (visual inspection sufficient for diagnosis). CT/MRI angiography – in all patients fit for surgery => To determine underlying vascular anatomy
493
SAH - Mx
4 weeks bed rest HTN control => Nimodipine – to prevent vasospasm (reduces mortality) – give to all if BP allows. IV fluids Analgesia, anti-emetics Stool softeners - to prevent straining Discuss with neurosurgery => Aneurysms may need to be coiled by interventional radiology or require neurosurgical clip => AVMs may require coiling or other neurosurgical intervention => Patients with hydrocephalus may need a shunt.
494
Subdural haemorrhage
= collection of blood in the subdural space, following the rupture of a vein. Usually following head injury, but can occur spontaneously. Patients are often young
495
ACUTE Subdural haemorrhage - presentation
Patients are often young, post-head injury Often occurs in severe acceleration-deceleration injuries Present to hospital with a dilated pupil and NO lucid interval before decreased GCS
496
SUB-ACUTE / SPONTANEOUS Subdural Haemorrhage - presentation
May occur spontaneously or after minor trauma. Can be bilateral Symptoms and signs of raised ICP, developing about 3 weeks after insult or start of bleed and often fluctuant: => Headache, drowsiness, confusion, focal neurological signs. Eventually stupor and coma due to coning.
497
ACUTE Subdural haemorrhage - Management and outcomes
CT head to confirm Craniotomy and early evacuation of the clot is required. These patients are often seriously ill even with early intervention. => Require ICU admission with intracranial pressure monitoring. High incidence of subsequent epilepsy, permanent neurological disability and high mortality.
498
RFs for subdural haemorrhage
- Head injury (acute) - Elderly (cortical atrophy stretches brittle veins) - Alcohol abuse - Other coagulopathies
499
SUB-ACUTE / SPONTANEOUS Subdural Haemorrhage - management
CT head to confirm Chronic subdural haemorrhage may resolve spontaneously. Progress can be assessed with serial imaging, but neurosurgical input is required.
500
Subdural haematoma - imaging
CT Acute SDH: - Classic CRESCENT-SHAPE with increased density, conforming to the contour of the skull. - May be accompanying midline shift and compression of ventricles. Chronic SDH: - Blood becomes more radiolucent (darker), and assumes a lentiform shape, similar to that of an extrdural haemorrhage.
501
Extradural haemorrhage
Most common in young patients following minor assault or sporting injury. Blow is usually to the side of the head, enough to cause a fracture and associated tearing of the middle meningeal artery. Blood accumulates rapidly over minutes to hours in the extradural space.
502
Extradural haemorrhage - presentation
Brief duration of unconsciousness, and then a LUCID recovery period. Progressive hemiparesis and stupor develops due to trans-tentorial coning. First there is an ipsilateral dilated pupil, then bilateral fixed dilated pupils. If untreated, there is hemiplegia and respiratory arrest.
503
Extradural haemorrhage - Ix
CT => characteristic LENTIFORM shape Midline shift and compression of the ventricles as it enlarges.
504
EDH vs SDH on CT
EDH = lentiform SDH = crescent
505
Extradural haemorrhage - Management
Urgent neurosurgical referral => Burr hole to release pressure => Prognosis is very good if this is performed early. If very minor, may be managed conservatively with regular monitoring.
506
Definition of stroke
= an acute, focal neurological deficit of cerebrovascular origin that persists >24 hours.
507
What % of strokes are ischaemic?
85% Either due to: - Arterial embolus from a distant site - Arterial thrombosis in atheromatous carotid/vertebral/basilar artery - Systemic hypoperfusion (general circulatory problem)
508
RFs for Ischaemic Stroke
MODIFIABLE HTN Hypercholesterolaemia Diabetes Smoking Alcohol Poor diet Low exercise Increased weight Use of oestrogen-containing OCPs NON-MODIFIABLE Age Family History Hypercoagulable states Non-white ethnicity AF
509
RFs for haemorrhagic stroke
Family History Uncontrolled HTN Vascular abnormalities (aneurysms, AVMs, HHT) Coagulopathies/anticoagulant therapies Heavy recent alcohol intake. Illicit drug use (mostly amphetamines and cocaine) Trauma
510
Ischaemic stroke - presentation
Facial weakness – sparing forehead. Contralateral limb weakness/hemiplegia and loss of sensation. => At first flaccid, but over time reflexes return and become exaggerated, with extensor plantars. Higher Dysfunction Visual Disturbances Seizures (rare)
511
Total Anterior Circulation Syndrome (TACS)
= Proximal MCA Occlusion Affecting the areas of the brain supplied by both the middle and anterior cerebral arteries Must have all three of: 1. Higher dysfunction (incl. decreased level of consciousness) 2. Homonymous hemianopia 3. Contralateral hemiplegia and/or sensory loss (>2 of face, arm, leg)
512
Partial Anterior Circulation Syndrome (PACS)
= distal MCA or ACA occlusion A less severe form of TACS, in which only part of the anterior circulation has been compromised. Requires 2 of the 3 TACS criteria.
513
Lacunar Syndrome (LACS)
= occlusion of lacunar branch of MCA leading to subcortical stroke There is no loss of higher cerebral functions (e.g. dysphasia). One of the following: - Pure motor symptoms - Pure sensory symptoms - Pure sensorimotor symptoms - Ataxic hemiparesis
514
What are possible features of higher dysfunction?
Expressive aphasia = inability to express language despite intact comprehension Receptive aphasia = inability to understand commands, may have fluent but meaningless speech. Apraxia = difficulty in performing task, despite intact motor function. Asterognosis = inability to identify objects in both hands, despite intact sensation. Agnosis = inability to recognise objects/people/sounds/smells despite the specific sense intact and no memory loss. Inattention (neglect) = inability to attend to stimuli despite intact senses.
515
Posterior Circulation Syndrome (POCS)
= PCA occlusion. There will be damage to the area of the brain supplied by the posterior circulation (e.g. cerebellum, thalamus, and brainstem). Presents as: - Cranial nerve palsy AND contralateral motor/sensory deficit. - Conjugate eye movement problems (e.g. nystagmus, double vision) - Cerebellar dysfunction - Isolated homonymous hemianopia
516
Oxford (Bamford) Classification of stroke
TACS PACS LACS POCS “Syndrome” describes indeterminate pathogenesis prior to imaging (e.g. TACS) => If confirmed infarct = TACI => If confirmed haemorrhage = TACH
517
Stroke - important factors from history
HPC: - Exact time of onset - Speed of onset - Body parts affected - Seizure at onset? PMH: - Previous stroke/MI - AF - DM - Abscess - Tumour? DHx: - Anticoagulants - OCP SHx: - Alcohol abuse, Smoking, Illicit drug use
518
Stroke - examination
GCS NIHSS – national institute of health stroke scale: => 15-item neurologic examination stroke scale => Evaluates level of consciousness, language, neglect, visual field loss, extra-ocular movement, motor strength, ataxia, dysarthria, and sensory loss. => Gives rapid insight into location of the stroke and severity – identifying those who may benefit from thrombolysis. CVS: => Murmurs (endocarditis), BP, HR, signs of dissection Respiratory: => SpO2, RR, crackles Neurological: => UMN/LMN signs => CNS and cerebellar examination
519
NIHSS / national institute of health stroke scale
15-item neurologic examination stroke scale Evaluates level of consciousness, language, neglect, visual field loss, extra-ocular movement, motor strength, ataxia, dysarthria, and sensory loss. Gives rapid insight into location of the stroke and severity – identifying those who may benefit from thrombolysis.
520
Stroke - investigations
ADMIT TO STROKE WARD IF POSSIBLE BLOODS: => FBC, U&Es, glucose + HbA1c, lipids, clotting screen, ESR BRAIN IMAGING: - MRI = gold-standard due to higher resolution, but less availability. - CT = rapid and commonly used, mainly used to exclude haemorrhage. Early signs of infarct can be seen as loss of grey-white differentiation, sulcal effacement, loss of insular ribbon
521
When is brain imaging within 1 hour indicated in stroke?
within 1 hour if: - Considering thrombolysis - Bleeding risk/headache at onset - Decreased consciousness - Neck stiffness
522
Stroke - Immediate Mx
A – E assessment => Always check glucose – hypoglycaemia is a common mimic. Withhold antiplatelet therapy until haemorrhage excluded => As soon as excluded, administer aspirin 300mg. If patient has had symptoms for over 30 minutes, but onset was within 4.5 hours – arrange THROMBOLYSIS. If thrombolysis is contraindicated – manage supportively on the ward, continuing 300mg aspirin daily for 2 weeks whilst implementing secondary prevention measures.
523
Stroke Management - thrombolysis
Check for contraindications first (must have lab blood results back) Alteplase 0.9 mg/kg as per clinical pathway within the hospital 10% bolus over 1 minute, remainder over 60 minutes.
524
Stroke - ward management
- SALT – swallow assessment ideally within 2 hours - PT – relieve spasticity and prevent contractures; early mobilisation is vital. - OT - Nursing – SSKIN bundle, early nutrition required if NBM - LMWH anticoagulation started on day 3 post-ischaemic stroke - Ensure TED stockings are being worn.
525
Care of a patient after Thrombolysis
Patient is closely monitored over 24 hours via cardiac monitor and has specific observations completed on stroke thrombolysis observation chart. If the patient develops severe headache, acute HTN, nausea or vomiting hen discontinue infusions and obtain emergency CT. Avoid catheterisation during the infusion Avoid aspirin or heparin for 24 hours. Avoid NG tube insertion for 1st 24 hours.
526
Stroke - secondary prevention
Identify and tackle lifestyle risk factors. => E.g. stop smoking, reduce alcohol, regular exercise, etc. Antihypertensive therapy = most important factor. => Start 2 weeks following stroke if elevated BP Antiplatelet therapy: => Aspirin 300mg for 2 weeks => Clopidogrel 75mg lifelong. Statin: => Offer from 48 hours post-stroke, regardless of cholesterol levels.   Manage co-morbidities appropriately: => Good AF control / anticoagulation, good diabetes control => Carotid USS Assessment of social care needs (+/- home assessments and modifications) => Independent patients can often become more dependent after a stroke
527
Stroke - impact on driving
Patients with normal license must not drive for 4 weeks following a stroke. After this period they may return to driving if clinical improvement is satisfactory, without needing to inform the DVLA.
528
Post-stroke complications
Malignant MCA syndrome DVT / PE Aspiration & hydrostatic pneumonia Pressure sores Depression Seizures Incontinence Post-stroke pain
529
Malignant MCA Syndrome
= Rapid neurological deterioration due to the effects of cerebral oedema following MCA territory stroke. High morbidity / mortality Mainly occurs in patients <60 Presentation – can be variable, high index of suspicion required: - Increased agitation / restlessness - Reducing GCS - Haemodynamic / thermal instability - Signs of raised ICP These patients require decompressive hemi-craniectomy
530
What is a TIA?
= an acute, focal neurological deficit of cerebrovascular origin that persists <1 hour, without signs of cerebral infarction on MRI scanning. Only diagnosed after resolution Can occur in brain, spinal cord or retina There is a very high risk of stroke within 4 weeks of a TIA.
531
What is Amaurosis Fugax ?
= sudden, transient loss of vision in one eye. Often occurs in TIA of the retina, can be the first clinical evidence of ICA stenosis. Can also occur due to ocular disease or migraine.
532
TIA - immediate management
Assess the patient’s immediate further stroke risk Immediate 300mg aspirin => Unless contraindicated, patient already anticoagulated or already taking aspirin 75mg daily. Consider admission if more than one recent TIA (crescendo TIA) or suspected carotid/cardio-embolic source Otherwise, arrange outpatient specialist TIA clinic assessment within 24 hours. => Can be within 7 days if TIA was >1 week ago. Give all people with suspected TIA and their family/carers information on the recognition of stroke and TIA and advise them to call 999 immediately if symptoms occur.
533
High risk features for further stroke after a TIA
Recurrent TIAs within a short period of time AF, or TIA whilst anticoagulated.
534
Driving advice post-TIA
Advise patient not to drive until seen by specialist in TIA clinic
535
TIA Management in TIA clinic
Carotid artery doppler – to assess for carotid artery stenosis If stenosis is >50% on affected side related to symptoms, carotid endarterectomy is offered: => Reduced risk of further stroke/TIA by 75% Alternative = percutaneous luminal angioplasty +/- stenting.
536
TIA - secondary prevention
As per stroke – will be initiated by secondary clinic Clopidogrel = antiplatelet of choice. (Aspirin and dipyridamole if clopidogrel is unsuitable)
537
What is multiple sclerosis?
= disease involving relapsing episodes of immunologically mediated (T-cell mediated) demyelination in the CNS, leading to neurological degeneration.
538
Common areas of demyelination in MS
Areas of demyelination are termed plaques (containing chronic inflammatory cells) Best seen in certain locations: - Optic nerves - Angles of the lateral ventricles - Cerebellar peduncles - Brainstem - Dorsal and corticospinal tracts
539
MS - symptoms
Symptoms are related to the common areas of demyelination: - Optic nerve => visual disturbances - Corticospinal tract => UMN deficit - Dorsal tract => sensory deficit - Cerebellar peduncles => cerebellar signs - Brainstem => bladder/bowel/sexual dysfunction - Cognitive impairment (late) In all forms of MS, episodes of neurological deficit appear irregularly throughout the CNS in terms of anatomical site and time.
540
Visual disturbances seen in MS
Optic neuritis is a common presenting feature Symptoms are: * blurring of vision over hours to days * Mild ocular pain (worse on movement) * Loss of colour vision O/E: * Decreased acuity and colour vision * Pink/swollen optic disc Diplopia is also common, due to brainstem involvement.
541
L’Hermitte’s sign
induce tingling sensations shooting down the arms/legs on neck flexion Due to posterior cervical demyelinating lesions in MS
542
Uthoff’s Phenomenon
MS symptoms are clinically worse during a fever, hot weather, or after exercise (as central conduction is slowed by increased body temperature)
543
what can cause of recurrence of MS symptoms?
Recurrence is unpredictable, with no clearly identified precipitating factors (although pregnancy / intercurrent illness may be implicated)
544
What are the different clinical patterns of MS?
Primary Progressive MS => No clear-cut relapses/remissions Relapsing/remitting MS (80-90%) => Initial episodes resolve completely => Subsequent events usually result in some residual disability. => Patients eventually develop secondary progressive MS (steady progression without remission) Fulminating MS => Debilitating progressive deterioration from an early stage.
545
MS - diagnosis
Clinically – two separate MS-like episodes of neurological dysfunction Diagnosis then conformed with MRI evidence of lesions
546
MS - Investigations
In primary care – NICE recommend doing: => FBC, U&E, LFT, ESR, TFT, glucose, calcium, B12 and HIV serology before referring to a neurologist. MRI => Will show lesions in 85% of patients with clinical disease => Lesions are not specific to MS, so clinical features are also required. CSF Examination: => Often unnecessary if MRI is diagnostic => Raised cell count and protein. => Electrophoresis shows oligoclonal IgG bands in 80% (non-specific) Visual Evoked Responses (VER): => Delayed occipital EEG reactions to visual stimuli are present in 95% of those with MS => Useful to demonstrate evidence of previous optic nerve lesions to demonstrate previous subclinical disease.
547
Acute MS Relapses - Management
1. Investigate appropriately to r/o other causes (particularly infection) 2. Consider admission if relapse is severe or patient cannot meet their social care needs at home. 3. High-dose Corticosteroids: - Oral methylprednisolone 500mg o.d for 5 days. - Start as soon as possible in the attack - May reduce severity of attack, no effect on long-term outcome. 4. Assess whether any increase in social care is required. 5. Patient education
548
Patient education in an acute MS relapse
Inform that steroids likely to reduce attack severity and duration, but may cause temporary mental health effects (confusion, anxiety, depression, psychosis) Significant recovery can be expected in 2-3 months, but there may be some residual symptoms.
549
MS - general management
Patients should be under the care of a specialised MS MDT, with annual review. Lifestyle advice: - Regular exercise can be beneficial - Smoking cessation improves disease course Prompt recognition and treatment of any co-existing illness => Illness/fever can frequently exacerbate MS symptoms Assess for and appropriately manage complications Disease modifying therapy (initiated by specialist).
550
MS - prognosis
Average life expectancy from diagnosis = 20-30 years There may be a long latent period (15-30 years) from an episode of optic neuritis before further Sx occur Poor prognostic factors: - Increased age of presentation - Early cerebellar involvement - Loss of mental functions
551
Visual Defect in Macula lesion
= Central Scotoma
552
Visual Defect in Optic Nerve lesion
= Ipsilateral Monocular Vision Loss
553
Visual Defect in Optic Chiasm lesion
= Bitemporal Hemianopia / Quadrantanopia Can get superior bitemporal quadrantanopia due to pressure from below the chiasm => E.g. pituitary tumour. Inferior bitemporal quadrantanopia is due to pressure from above the chiasm => E.g. craniopharyngioma, carotid aneurysm, meningioma.
554
Visual Defect in Optic tract lesion
= Contralateral Homonymous Hemianopia
555
Visual Defect - Optic radiation lesion
= Contralateral Homonymous Quadrantanopia Temporal lesions = inferior fibres (superior retina) => superior homonymous hemianopia Parietal lesions = superior fibres (inferior retina) => inferior homonymous hemianopia
556
Visual Defect - visual cortex due to PCA lesion
Homonymous hemianopia / quadrantanopia with Macular Sparing (macula gets blood supply from both PCA and MCA).
557
Broca’s Area
Motor speech function Located in inferior frontal gyrus, areas 44 + 45
558
Wernicke's Area
Involved in understanding of the spoken word Located in superior temporal gyrus, area 22
559
Broca’s Aphasia
= expressive aphasia, loss of ability to produce speech. Non-fluent – verbal output reduced Comprehension is good, repetition is poor
560
Wernicke’s Aphasia
= receptive aphasia, loss of ability to understand speech Fluent – normal production of incorrect words Poor comprehension, poor repetition.
561
Global Aphasia
= Both expressive and receptive dysphasia
562
What is dysarthria?
= disordered articulation / slurred speech, language remains intact
563
Causes of dysarthria
Bulbar palsy => LMN, high-pitched nasal speech Pseudobulbar palsy => UMN, “Donald duck” gravelly speech Cerebellar lesion => Slow, jerky/staccato, slurred speech Extrapyramidal lesions => Soft, indistinct, monotonous speech Myasthenia Gravis => Speech fatigues and dies away
564
What causes Horner's Syndrome? What are the triad of signs?
= oculo-sympathetic palsy, caused by interruption of the sympathetic chain. 1. Unilateral pupillary constriction (miosis). 2. Partial ptosis => Loss of Muller’s muscle, only slight LPS intact 3. Anhidrosis In congenital/long-standing lesions, heterochromia will develop
565
Causes of Horner's Syndrome
Due to the interruption of the sympathetic chain in the level of the first, second or third order neurone: First order: => Brainstem disease – tumour, stroke, MS, syphilis Second order: => Intrathoracic lesions – Pancoast tumour, cervical rib, TB => Neck lesions – lymphadenopathy, trauma, thyroid surgery Third order: => ICA aneurysm => Migraine (transient) => Idiopathic
566
RFs for venous sinus thrombosis
Pro-thrombotic risk factors: - Oral contraceptives - Pregnancy / puerperium - Malignancy - Genetic thrombophilia Head injury Recent LP Infection
567
Venous sinus thrombosis - pathology
Venous infarction leads to vascular congestion. Eventually there is haemorrhagic necrosis It can be split into cortical venous thrombosis and dural venous sinus thrombosis
568
Cortical Venous Thrombosis - presentation
Ocular pain, worse on movement Proptosis and chemosis Ophthalmoplegia Papilloedema Fever
569
Dural venous Sinus Thrombosis - presentation
Signs of raised ICP (headache, vomiting, fever, papilloedema, seizures).
570
Venous sinus thrombosis - Ix
CT – often normal LP – raised ICP CT/MRI venography may be required for diagnosis Suspect venous sinus thrombosis if there is thunderclap headache and raised ICP, with no signs of meningitis and no changes on CT.
571
What is shingles? How does it typically present?
= reactivation of varicella zoster infection within the dorsal root ganglia. Most commonly occurs in the lower thoracic dermatomes: - Pain and paraesthesia for several days - Erythema and a dermatomal eruption of vesicles - Increased burning and itching - Vesicles become pustular 2-3 days later and may separate 3 weeks later.
572
Ophthalmic Shingles
Infection of the 1st division of the 5th nerve. Can lead to uveitis, corneal scarring and secondary pan-ophthalmitis
573
Ramsey-Hunt Syndrome - presentation
VZV infection of the geniculate ganglion. Clinical features: - Facial palsy (often severe and irreversible) - Facial/ear pain - Vesicles in the ear canal, pinna and soft palate. May also be sensorineural deafness and vertigo and neuropathy of nerves 5, 9 & 10.
574
Ramsey-Hunt Syndrome - Mx
5-7 days oral acyclovir Paracetamol and amitriptyline for pain
575
Post-herpetic Neuralgia
Pain in previous shingles zone, occurring in 10% Burning, continuous pain Responds poorly to analgesia Amitriptyline is commonly used, plus topical capsaicin Associated with depression Gradual recovery over ~2 years
576
Intracerebral space occupying lesion - presentation
Presentation is dependent on the location of the tumour and its rate of growth: Signs/symptoms of raised ICP => Headache (morning/lying down), N&V, papilloedema Epileptic Seizures => Adults with an epileptic fit have a brain tumour until proven otherwise. Progressive neurological deterioration: - Increasing weakness - Sensory loss - Cranial nerve palsies - Dysphasia (if involving the dominant hemisphere)
577
Intracerebral space occupying lesion - Ix
These patients need urgent admission for investigation: - Early CT with contrast - MRI if no mass can be seen on CT
578
Intracerebral space occupying lesion - Mx
Dexamethasone 4-6mg QDS if any neurological deterioration/drowsiness Anticonvulsants – if presented with epilepsy Refer to neuro-oncology MDT => Neurosurgical intervention if accessible, often with adjunctive radiotherapy.
579
What is paraneoplastic syndrome?
= a cluster of symptoms that occur in patients with cancer, that cannot be explained by the tumour/metastases or hormones normally secreted by the primary tissue from which the tumour arose. Seen in ~10% of patients with advanced malignant disease.
580
What paraneoplastic syndromes involve the nervous system ?
Myasthenia Gravis Lambert-Eaton Myasthenic syndrome Paraneoplastic sensory neuropathy Paraneoplastic cerebellar degeneration
581
Paraneoplastic cerebellar degeneration - Presentation - Associated conditions
=> Gives classic cerebellar signs – e.g. ataxic gait, dizziness, dysarthria => Frequently associated with Hodgkin’s Lymphoma, breast cancer, small cell lung cancer and ovarian cancer.
582
What are the 3 most common adult primary brain tumours?
malignant glioma, meningioma, and astrocytoma
583
Malignant Glioma
Most common adult primary malignancy, originating from astrocytes. Rapidly growing, thus present with signs of raised ICP Poor prognosis, with death often within 6 months of diagnosis
584
Meningioma
Generally benign, slow growing tumours arising from the meninges Surgical excision and debulking is undertaken wherever possible. Good prognosis following surgical excision.
585
Astrocytoma
Benign, slow-growing tumour that occur in young people. Can turn malignant in later life.
586
Ependymoma
Originate from the ependymal cells lining the ventricles Most common in young people/children Usually malignant, but do not tend to recur after removal
587
Acoustic Neuroma (Schwannoma)
Arise from the Schwann cells of the acoustic nerve More common in neurofibromatosis type II Presents with progressive unilateral sensorineural deafness, tinnitus, vertigo, facial nerve palsy. Tumour growth can cause cerebellar symptoms or bulbar palsy.
588
Brain mets - most common primary tumour locations
- Bronchus - Breast - Kidney - Colon - Thyroid - Malignant melanoma
589
Vasovagal/cardiogenic syncope
= “simple faint” Due to sudden reflex bradycardia and peripheral vasodilation Occurs in response to standing, fear, venesection or pain. Patient is unconscious for less than 2 minutes. Recovery is rapid Treatment is not necessary
590
Causes of syncope
Vasovagal Postural hypotension Post-prandial hypotension Carotid sinus syncope (excessive vagal response – e.g. wearing tight collars). Anaemic syncope Micturition syncope (in men, due to parasympathetic overactivity). Coughing or exertion syncope.
591
Definition of postural hypotension
Drop in SBP of 20mmHg or more on standing from a sitting/lying position. => Measure sitting, and then at 1, 2 and 3 minutes after standing up. Occurs due to blood pooling in the legs due to the influence of gravity
592
Postural hypotension - RFs
- Fluid depletion - Age-related autonomic dysfunction - Polypharmacy (vasodilating/diuretic drugs).
593
Definition of post-prandial hypotension
Drop in SBP of 20mmHg (or DBP of 10mmHg) after eating, due to pooling of blood in the splanchnic vasculature. Thought to be even more common than postural hypotension.
594
Seizure vs syncope
This is a clinical differentiation: => Witnessed jerking movements, incontinence, post-episode confusion and amnesia highly suggestive of a seizure. Cardiac evaluation can detect RFs for syncope (arrythmias, mechanical issues, etc.)
595
Investigations for recurrent syncope
Advise patient against driving whilst undergoing investigation for the cause. Investigations: - Bloods – FBC, U&E, glucose - L/S BP or tilt table tests - ECG / 24-hour tape (heart block , arrythmias, long QT) - EEG/ sleep EEG - Echo - CT head
596
What are the 3 types of muscle diseases?
1. Muscular Dystrophies - Genetically determined diseases that result in progressive deterioration. 2. Myopathies: - Diverse group of conditions that are grouped due to their predominant effect on muscle. 3. Neurogenic disease: - Disease of peripheral nerves or motor neurones that cause secondary skeletal muscle atrophy.
597
Muscular Dystrophies
Duchenne Muscular Dystrophy Becker Muscular Dystrophy Myotonic Dystrophy
598
What is Duchenne Muscular Dystrophy?
Most common muscular dystrophy X-linked recessive, seen exclusively in males. => Can be spontaneous mutations Caused by a mutation in the dystrophin gene, making muscle fibres liable to break down with repeated contraction.
599
Duchenne Muscular Dystrophy - Presentation
Onset in early childhood: - Global muscle weakness - Calf pseudohypertrophy – due to fatty replacement of muscle. - Gower’s sign – uses hands to climb up to standing. Prognosis is poor – patients usually die in late teens due to respiratory failure and cardiomyopathy
600
Duchenne Muscular Dystrophy - investigations
- Raised CK - Genetic testing / muscle biopsy can confirm Dx
601
What is Becker Muscular Dystrophy ?
Less common, producing partially functioning dystrophin As such, symptoms are milder and prognosis is better than Duchenne Patients generally survive until mid-40s.
602
Myotonic Dystrophy - inheritance
Autosomal dominant condition, caused by a chloride channelopathy Shows “anticipation”, with symptoms more severe in each generation => Due to expansion of CTG repeat
603
Myotonic Dystrophy - presentation
Characterised by muscle weakness and myotonia => Inability to relax muscles Usually becomes apparent in adolescence, with facial and lower limb weakness. Also associated with non-muscular features: => Cataracts, frontal baldness, mental impairment, cardiac abnormalities.
604
Muscle Disorders - investigations
Serum muscle enzymes – Creatine Kinase => Raised in muscular dystrophies and inflammatory muscle disorders => Normal in MG Electromyography: => Classical trace for myopathy, denervation, myotonic discharges and in MG. Muscle biopsy: => Can differentiate between denervation and muscular disease.
605
Management of a patient with impaired motor function
manage as per the REPAIR mnemonic. Spasticity: - Physical Mx => PT, gait retraining, removal of exacerbating stimuli (e.g. constipation, UTI, pressure ulcers). - Surgical Mx: => Tendon lengthening, releases for fixed deformities, electrostimulation therapy. - Medical Mx: => Baclofen, dantrolene, benzodiazepines, botox injections. Contractures: - Aim to prevent development with good management of spasticity - If contractures are present, orthopaedic referral may be appropriate. - PT and aids are also appropriate.
606
Causes of delirium
Drugs/dehydration => Drugs – withdrawal/new/toxicity => including opiates, antihistamines, BZDs, antipsychotics, antimuscarinics, alcohol. Electrolyte imbalance Level of pain Infection/inflammation Respiratory failure / Reduced sensory input Impaction of faeces / Intracranial Urinary retention Metabolic / MI
607
Symptoms of delirium
Symptoms depend on the type. HYPERACTIVE: * Abnormally alert, Agitation/restlessness, disorientation, hallucinations, aggression, wandering, inappropriate behaviour. * Tx – delirium pathway HYPOACTIVE: * More common * Often unrecognised (so increased mortality), presents similar to depression. * Withdrawn, not eating/drinking, drowsy, disorganised. Can also have a mixed delirium.
608
Delirium - Investigations
Collateral Hx (establish baseline cognition). Physical examination (conscious level, infection, neurology). Confusion Bloods => FBC, CRP, U&Es, LFTs, TFTs, glucose, Ca, B12, folate Urinalysis CXR, ECG, CT/MRI Assess nutritional status Medication review
609
Delirium - Mx
Treat the underlying cause (if ignored => high mortality). Reduce medications – avoid opiates, anticholinergics. Reassure and keep orientated, active, hydrated, nourished. Optimise senses and promote good sleep hygiene. Only use drugs if other interventions have failed and patient is a risk to themselves or others. - Haloperidol 0.5mg = 1st line - Lorazepam 0.5mg (if haloperidol is contraindicated – Parkinson’s, LB dementia). - Only use short-term (usually 1 week or less).
610
What is the classical triad of Parkinsonism?
1. Tremor 2. Rigidity 3. Bradykinesia
611
Parkinsonism - tremor
4 – 7 Hz Characteristic “pill-rolling” movement between thumb and finger Occurs at rest Decreases with action (e.g. on finger-to-nose test) Increases with anxiety/anger/excitement Positive glabellar tap sign (tap smooth part of the forehead above the nose and between the eyebrows) => Leads to excessive blinking
612
Parkinsonism - rigidity
Increased tone throughout the range of limb movement It is equal in opposing muscle groups, giving “lead pipe” rigidity Patient may have problems getting up from a chair
613
Parkinsonism - bradykinesia
Difficulty initiating movement Progressive reduction in speed/amplitude of repetitive actions Spontaneous blinking rate is reduced. Facial immobility gives mask-like face => hypomimia. Combined with hypersalivation => drooling
614
Causes of parkinsonism
Idiopathic = Parkinson’s disease Drug-induced: => Neuroleptics, prochlorperazine, metoclopramide, TCAs, methyldopa Vascular: => Multiple cerebral infarcts Toxin induced => Wilson’s disease Post-encephalopathy Parkinson’s-plus Syndromes
615
What are the Parkinson's plus syndromes?
= Rare alternative causes that should be screened for before diagnosing with Parkinson’s disease. - Progressive Supranuclear Palsy - Multiple system atrophy - Lewy Body Dementia - Vascular Parkinsonism - Cortico-basal degeneration
616
Parkinson's Plus - Progressive Supranuclear Palsy
- Symmetrical onset, tremor is unusual - Early postural instability (falls) - Dementia develops early - Vertical gaze palsy ( = limitation of movement in down gaze)
617
Parkinson's Plus - Multiple system atrophy
Early autonomic features * Postural hypotension, bladder dysfunction, excess sweating Cerebellar signs also present * Nystagmus in horizontal gaze Pyramidal (UMN) signs present * Extensor plantars, hyperreflexia
618
Parkinson's Plus - Lewy Body Dementia
Early dementia, with fluctuating cognition and visual hallucinations. Symmetrical motor signs
619
Parkinson's Plus - Vascular Parkinsonism
Strokes affecting basal ganglia Symptoms worse in legs than arms Pyramidal signs present
620
Parkinson's Plus - Cortico-basal degeneration
Akinetic rigidity involving one limb Cortical sensory loss – e.g. asterognosis
621
Idiopathic Parkinson's Disease - pathology
= A neurodegenerative disorder Caused by a loss of the dopamine producing cells in the Substantia Nigra. The results in REDUCED DOPAMINE ACTIVITY within the corpus striatum of the basal ganglia, leading to Parkinsonism. 60% of nigrostriatal neurones have to be lost before symptoms appear. => Surviving neurones increase dopamine production => Target striatal neurones increase receptor number.
622
Idiopathic Parkinson's Disease - Presentation
Onset is typically asymmetrical and there is persistent asymmetry in the severity of the classical triad of Parkinsonism. Motor and Non-motor symptoms
623
Parkinson's Disease - MOTOR symptoms
* Bradykinesia * Rigidity * Postural instability * Resting tremor * Freezing => Narrow/confined spaces => Changing direction * Dystonia (painful cramping in feet/legs) - worse at night * Dysphagia * “Classic Parkinson’s Gait” – shuffling/small steps, stooped over, reduced arm swings.
624
Parkinson's Disease - NON-MOTOR symptoms
* Masked face * Hypophonia (deep, soft, monotonous voice) * Micrographia (progressively smaller handwriting) * Depression/anxiety * Psychosis * Anosmia * Insomnia/REM sleep disorder/restless legs * Fatigue * Constipation/urinary incontinence * Seborrhoeic dermatitis * Cognitive impairment
625
Parkinson's Disease - Diagnosis
Diagnosis is clinical, after ruling out other causes of Parkinsonism.
626
Parkinson's Disease - Mx
There is no cure. Care should be under a specialist MDT, including a Parkinson’s nurse. 1. Levodopa Monotherapy 2. Dopamine Receptor Agonists 3. Levodopa Dual Therapy – Dopamine Metabolism inhibitor 4. Non-pharmacological - Patient education – advice to minimise “freezing” - Comprehensive Geriatric Assessment - Social support - Physio/OT 5. Treatment of Non-motor Symptoms - Constipation – dietary fibre, water, mild osmotic laxatives. - Urinary incontinence – timed voids, bladder antispasmodics. - Sleep – make sleeping environment safer. - Orthostatic hypotension – reduce/stop antihypertensives or diuretics, possibly fludrocortisone/midodrine.
627
Levodopa Monotherapy in management of Parkinson's
A dopamine precursor (dopamine itself cannot cross the BBB). Acts to increase synaptic dopamine. Combined with carbidopa to prevent peripheral metabolism to dopamine (but cannot cross the BBB so allows action of L-dopa in the CNS). Usual maximum dose 600-1000mg / day Complications may arise after 4-6 years and efficacy reduces (narrowed therapeutic window). SEs – dyskinesia (uncontrollable wriggling), confusion, depression, insomnia.
628
Dopamine Receptor Agonists in management of Parkinson's
e.g. Ropinirole, Rotigotine (patch), bromocriptine Activates post-synaptic receptors. Can be used as monotherapy in early disease to delay the use of L-dopa, or can be used as an adjunct to L-dopa. Generally less effective, but cause fewer unwanted dyskinesias. SEs – confusion, hallucinations, impulsive control disorder (gambling, hypersexuality).
629
Levodopa Dual Therapy in management of Parkinson's
[1] Dopamine Metabolism inhibitors: MAO-B inhibitors (selegiline/rasagiline) * Can increase duration of response to L-dopa. * SE – postural hypotension [2] COMT inhibitors (entacapone) * Block L-dopa metabolism * SEs – sleepiness, hallucinations, impulsiveness. [3] Amantadine – useful if prominent dyskinesias.
630
What is Radiculopathy?
= Process affecting nerve roots
631
What is Neuropathy ?
= Pathological process affecting a peripheral nerve(s)
632
What is Mononeuropathy ?
= Process affecting a single nerve
633
What is Mononeuropathy ?
= Process affecting a single nerve
634
What is Mononeuritis Multiplex?
= Process affecting several individual nerves
635
What is Polyneuropathy / peripheral neuropathy ?
Diffuse, symmetrical disease, usually beginning peripherally. Can be motor/sensory/autonomic or combinations of these Can be broadly classified into demyelinating or axonal types. Widespread loss of tendon reflexes is usual, as well as “glove and stocking” sensory loss.
636
What drugs can cause peripheral neuropathy?
Amiodarone, statins, hydralazine, phenytoin, ABX
637
What are the 4 most common causes of peripheral neuropathy?
DM, Carcinomatous neuropathy (myeloma/paraneoplastic syndrome) B-vitamin deficiency Drugs.
638
Demyelinating vs axonal neuropathy
Can be separated by nerve conduction studies DEMYELINATING: - Damage spares axons, but affects Schwann cells, more common in immune-mediated disease such as GBS - Inferred by decreased conduction velocity - Schwann cells can regrow, so will improve with Tx AXONAL: - Nerve cell bodies are unable to maintain long axonal processes, leading to degeneration that starts at the periphery, progressing upwards to the neuronal cell. - Inferred by reduced amplitude of nerve impulses - Axons cannot regrow, thus treatment outcomes are poor.
639
At what rate can nerves regenerate?
Providing the cell bodies are intact, the nerves are able to regenerate at a rate of up to 1mm per day.
640
Peripheral Neuropathy - Ix
Bloods: - FBC, U&E, LFTs, HbA1c, B12/folate - ANCA, VDRL (syphilis), autoantibodies Nerve conduction studies => Demyelinating or axonal? LP: => Raised protein in GBS / CIDP Peripheral nerve biopsy if diagnosis uncertain.
641
How is non-alcoholic fatty liver disease (NAFLD) diagnosed?
Diagnosis involves: 1) ruling out other causes of hepatomegaly (such as alcoholism, viral hepatitis, and auto-immune liver disease) 2) evidence of of hepatic steatosis (liver biopsy or radiology)
642
Causes of transient or spurious non-visible haematuria
urinary tract infection menstruation vigorous exercise (this normally settles after around 3 days) sexual intercourse
643
Causes of persistent non-visible haematuria
cancer (bladder, renal, prostate) stones benign prostatic hyperplasia prostatitis urethritis e.g. Chlamydia renal causes: IgA nephropathy, thin basement membrane disease
644
Sick euthyroid syndrome
low T3/T4 levels alongside an inappropriately normal TSH in the context of an acutely unwell patient Changes are reversible upon recovery from the systemic illness and hence no treatment is usually needed.
645
ALARMS 55 Symptoms
- Anaemia (iron deficient) - Loss of weight - Anorexia - Recent onset, progressive symptoms - Melaena or haematemesis - Swallowing difficulties. - >55 years of age
646
How should a patient be counselled for risks of antithyroid medications?
AGRANULOCYTOSIS - Advise (including in writing) to see their GP immediately if they develop any signs of mouth ulceration, sore throat or fever.